From Casetext: Smarter Legal Research

Romero-Lorenzo v. Koehn

United States District Court, D. Arizona
Mar 29, 2023
665 F. Supp. 3d 1056 (D. Ariz. 2023)

Opinion

No. CV-20-00901-PHX-DJH (ESW)

2023-03-29

Claudia ROMERO-LORENZO, et al., Plaintiffs, v. Brian KOEHN, et al., Defendants.

Aditi Shah, Pro Hac Vice, Alejandro Agustin Ortiz, Pro Hac Vice, Emma A. Andersson, Pro Hac Vice, ACLU, New York, NY, Benjamin C. Calleros, Jean-Jacques Cabou, Margo Rose Casselman, Matthew Robert Koerner, Thomas Dean Ryerson, Perkins Coie LLP, Phoenix, AZ, Christine Keeyeh Wee, Jared G. Keenan, ACLU, Phoenix, AZ, Corene T. Kendrick, Pro Hac Vice, David Cyrus Fathi, Pro Hac Vice, Somil Bharat Trivedi, Pro Hac Vice, ACLU, Washington, DC, Kyle A. Virgien, Pro Hac Vice, ACLU, San Francisco, CA, Mark Carter, Pro Hac Vice, Native American Rights Fund, Boulder, CO, for Plaintiffs Claudia Romero-Lorenzo, Tracy Ann Peuplie, James Tyler Ciecierski, Marvin Lee Enos. Daniel Patrick Struck, Jacob Brady Lee, Nicholas Daniel Acedo, Rachel Love, Struck Love Bojanowski & Acedo PLC, Chandler, AZ, for Defendant Kris Kline. William Charles Staes, U.S. Attorney's Office, Phoenix, AZ, for Defendants Donald W. Washington, Michael Carvajal, Van Bayless.


Aditi Shah, Pro Hac Vice, Alejandro Agustin Ortiz, Pro Hac Vice, Emma A. Andersson, Pro Hac Vice, ACLU, New York, NY, Benjamin C. Calleros, Jean-Jacques Cabou, Margo Rose Casselman, Matthew Robert Koerner, Thomas Dean Ryerson, Perkins Coie LLP, Phoenix, AZ, Christine Keeyeh Wee, Jared G. Keenan, ACLU, Phoenix, AZ, Corene T. Kendrick, Pro Hac Vice, David Cyrus Fathi, Pro Hac Vice, Somil Bharat Trivedi, Pro Hac Vice, ACLU, Washington, DC, Kyle A. Virgien, Pro Hac Vice, ACLU, San Francisco, CA, Mark Carter, Pro Hac Vice, Native American Rights Fund, Boulder, CO, for Plaintiffs Claudia Romero-Lorenzo, Tracy Ann Peuplie, James Tyler Ciecierski, Marvin Lee Enos. Daniel Patrick Struck, Jacob Brady Lee, Nicholas Daniel Acedo, Rachel Love, Struck Love Bojanowski & Acedo PLC, Chandler, AZ, for Defendant Kris Kline.

William Charles Staes, U.S. Attorney's Office, Phoenix, AZ, for Defendants Donald W. Washington, Michael Carvajal, Van Bayless.

ORDER

Diane J. Humetewa, United States District Judge

Plaintiffs Claudia Romero-Lorenzo, Tracy Ann Peuplie, James Tyler Ciecierski, and Marvin Lee Enos, federal pre-trial detainees who are or were confined in CoreCivic's Central Arizona Florence Correctional Complex (CAFCC), initiated this civil rights class action for declaratory and injunctive relief on behalf of themselves and all similarly situated individuals confined at CAFCC. (Doc. 1.) Plaintiffs claim that Defendants failed to take reasonable measures to protect them from exposure to COVID-19 in violation of their Fifth Amendment due process rights. (Id.) Defendants Van Bayless, Acting United States Marshall for the District of Arizona, Donald Washington, Director of the U.S. Marshall's Service, and Michael Carvajal, Director of the Federal Bureau of Prisons (BOP) (collectively "Federal Defendants") and Defendant Kris Kline, Warden of the CAFCC, filed separate Motions for Summary Judgment. (Doc. 187; Doc. 194.) Federal Defendants and Defendant Kline also joined in each others' Motions. (Doc. 195; Doc. 197.) Both Motions are fully briefed. (Doc. 208, 209, 213, 221).

Some originally named Plaintiffs asserted claims on behalf of all similarly situated convicted prisoners confined at CAFCC for alleged violations of their Eighth Amendment rights to be free from cruel and unusual punishment, and the Court certified two sets of classes: a Pretrial Class, and a Post-Conviction Class. (Doc. 69.) After class certification, the Court dismissed Plaintiffs' Eighth Amendment claims for failure to state a claim. (Doc. 89.) The Court also dismissed Plaintiffs' claims seeking release under § 1331 and/or writs of habeas corpus under § 2241 for lack of subject matter jurisdiction. (Id.)

A separate set of Plaintiffs representing a Post-Conviction Class brought claims under the Eighth Amendment, but the Court dismissed those claims for failure to state a claim. (Doc. 89.) The Court also dismissed Plaintiffs' claims seeking release under 28 U.S.C. § 1331 and/or writs of habeas corpus under § 2241 for lack of subject matter jurisdiction. (Id.)

Plaintiffs also filed a Motion to Exclude the Findings and Opinions of Defendants' Expert Dr. Owen J. Murray (Doc. 185) and Defendant Kline's Daubert Motion to Exclude the Testimony of Homer Venters (Doc. 189).

The Court will grant the Motion for Summary Judgment in part, deny it in part, and deny the parties' Motions to Exclude.

I. Motions to Exclude Expert Opinions

"Under Rule 702 of the Federal Rules of Evidence, [a] witness who is qualified as an expert by knowledge, skill, experience, training, or education may testify in the form of an opinion, provided the testimony meets certain criteria." United States v. Gadson, 763 F.3d 1189, 1202 (9th Cir. 2014) (quotation marks and citation omitted). An expert witness may rely on information, such as hearsay evidence, that would not be admissible on its own. Fed. R. Evid. 703. Expert testimony is sufficiently "reliable if the knowledge underlying it has a reliable basis in the knowledge and experience of [the relevant] discipline." United States v. Sandoval-Mendoza, 472 F.3d 645, 654 (9th Cir. 2006) (quotation marks and citation omitted). The test for admissibility "is not the correctness of the expert's conclusions but the soundness of his methodology." Primiano v. Cook, 598 F.3d 558, 564 (9th Cir. 2010) (quotation marks and citation omitted).

Both parties' experts have relevant knowledge and experience. The parties disagree about the soundness of some experts' methodologies, but those disputes,

as well as the appropriate weight to assign to each expert's opinions, are more properly addressed at trial. The parties' expert reports are, therefore, admissible, and the Court will deny both Motions to Exclude.

II. Summary Judgment Standard

A court must grant summary judgment "if the movant shows that there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law." Fed. R. Civ. P. 56(a); see also Celotex Corp. v. Catrett, 477 U.S. 317, 322-23, 106 S.Ct. 2548, 91 L.Ed.2d 265 (1986). The movant bears the initial responsibility of presenting the basis for its motion and identifying those portions of the record, together with affidavits, if any, that it believes demonstrate the absence of a genuine issue of material fact. Celotex, 477 U.S. at 323, 106 S.Ct. 2548.

If the movant fails to carry its initial burden of production, the nonmovant need not produce anything. Nissan Fire & Marine Ins. Co., Ltd. v. Fritz Co., Inc., 210 F.3d 1099, 1102-03 (9th Cir. 2000). But if the movant meets its initial responsibility, the burden shifts to the nonmovant to demonstrate the existence of a factual dispute and that the fact in contention is material, i.e., a fact that might affect the outcome of the suit under the governing law, and that the dispute is genuine, i.e., the evidence is such that a reasonable jury could return a verdict for the nonmovant. Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 248, 250, 106 S.Ct. 2505, 91 L.Ed.2d 202 (1986); see Triton Energy Corp. v. Square D. Co., 68 F.3d 1216, 1221 (9th Cir. 1995). The nonmovant need not establish a material issue of fact conclusively in its favor, First Nat'l Bank of Ariz. v. Cities Serv. Co., 391 U.S. 253, 288-89, 88 S.Ct. 1575, 20 L.Ed.2d 569 (1968); however, it must "come forward with specific facts showing that there is a genuine issue for trial." Matsushita Elec. Indus. Co., Ltd. v. Zenith Radio Corp., 475 U.S. 574, 587, 106 S.Ct. 1348, 89 L.Ed.2d 538 (1986) (internal citation omitted); see Fed. R. Civ. P. 56(c)(1).

At summary judgment, the judge's function is not to weigh the evidence and determine the truth but to determine whether there is a genuine issue for trial. Anderson, 477 U.S. at 249, 106 S.Ct. 2505. In its analysis, the court must believe the nonmovant's evidence and draw all inferences in the nonmovant's favor. Id. at 255, 106 S.Ct. 2505. The court need consider only the cited materials, but it may consider any other materials in the record. Fed. R. Civ. P. 56(c)(3).

III. Facts

CAFCC is a private detention facility owned and operated by CoreCivic, Inc., in Florence, Arizona. (Doc. 188, Federal Defendants' Statement of Facts (FDSOF) ¶ 1.) The United States' Marshals Service (USMS) contracts with CAFCC to house prisoners who have been remanded to USMS custody by a federal judicial officer. (Id. ¶ 2.) Under this contract, CAFCC must provide secure custody, safekeeping, housing, subsistence, and care of USMS prisoners in accordance with all state and local laws, regulations, policies, and court orders applicable to the operation of the facility, including the Federal Performance Based Detention Standards. (Id. ¶¶ 3-4.)

The USMS follows CDC guidance for responding to COVID-19 at detention facilities holding USMS prisoners and has sent CDC guidance to those facilities. (Id. ¶¶ 5-6.) The USMS also conducts Quality Assurance Reviews (QARs) or audits at these facilities to ensure compliance with their contract terms and applicable standards and to ensure that non-federal detention facilities are operated in a safe, humane, and secure manner. (Id. ¶¶ 7-8.) In August 2020, the USMS conducted a QAR of CAFCC and concluded that CAFCC staff

were following applicable CDC COVID-19 pandemic guidelines at that time. (Id. ¶ 9.)

A. CoreCivic/CAFCC's COVID-19 Response

In January 2020, CoreCivic began monitoring the COVID-19 outbreak. (Doc. 192, Def. Kline's Statement of Facts (DKSOF) ¶ 33.) CoreCivic's Facility Support Center (FSC) in Brentwood, Tennessee developed company-wide protocols for responding to COVID-19 at each of its facilities based on recommendations from the CDC, government partners, and state and local health authorities. (Id. ¶ 31.) The FSC also activated an Emergency Operations Center (EOC) to communicate with all CoreCivic facilities regarding daily developments in COVID-19 information, CDC guidance, and operational management. (Id. ¶ 32.) CoreCivic's Chief Medical Officer, Dr. Keith Ivans, worked closely with infectious disease specialists and correctional medical professionals to implement up-to-date protocols for preventing the spread of COVID-19 in each CoreCivic correctional facility. (Id. ¶ 34.)

Early in the pandemic, CoreCivic facility administrators had daily and as-needed conference calls with the EOC to review protocols, receive CDC updates, and discuss concerns and requests related to the COVID-19 response; currently, these calls happen biweekly. (Id. ¶ 35.)

As of May 2020, CAFCC leadership and supervisory staff were holding daily briefings to discuss issues and assign tasks for COVID-19 operational responses. (Id. ¶ 38.) CAFCC developed and followed COVID-19 Sanitation Schedules and Protocols for daily facility cleaning and sanitation. (Id. ¶ 39.) CAFCC also developed a staffing contingency plan in the event of staffing shortages due to the virus, and restricted detainee movement to prevent COVID-19 exposure, which freed up staff to meet needs in other operational areas. (Id. ¶ 40.)

CAFCC monitors changes in guidance from the CDC and the Pinal County Public Health Services District (Pinal County), and Pinal County has reviewed and approved CAFCC's quarantine, isolation, testing, and vaccination plans. (Id. ¶¶ 46-47.)

B. CAFCC Policies and Practices for Reducing the Spread of COVID-19

1. Social Distancing

To limit the spread of the virus, in March and April 2020, CAFCC suspended all social visits and volunteer entry into the facility and stopped transporting detainees for in-person court hearings or non-emergency medical consults, although it has since resumed these activities with certain restrictions. (Id. ¶¶ 51-53.)

CAFCC implemented other practices to promote social distancing, consistent with CDC guidelines, including staggering time in recreational spaces, restricting recreation to a single housing unit per area, providing meals inside cells or housing units, suspending group programming, using outdoor facilities for existing group activities, having designated rooms near each housing unit to evaluate detainees with COVID-19 symptoms, and having healthcare staff perform regular rounds. (Id. ¶ 59.) Even after detainees began receiving vaccinations, CAFCC's overall policies regarding social distancing and housing have not changed. (Id. ¶ 68.)

2. Masks and Other Personal Protective Equipment (PPE)

CAFCC's protocols regarding masking and PPE evolved along with CDC guidance. (DKSOF ¶¶ 69-73.) The May 3, 2022 CDC Guidance provides "Strategies for Everyday Operations," and "Enhanced

COVID-19 Prevention Strategies," and explains that correctional facilities should keep strategies for everyday operations in place at all times and should add enhanced COVID-19 prevention strategies "when the COVID-19 Community Level is medium or high, or when facility-level factors indicate increased risk." (DKSOF ¶ 75; Doc. 192-2 at 89-90.) Facility-level factors include (1) vaccination coverage, (2) transmission within the facility, (3) staff/detainee risks of severe health outcomes, and (4) facility structural and operational characteristics. (DKSOF ¶ 75.) For everyday operations, the Guidance recommends that facilities offer "well-fitting masks/respirators" to residents and staff, while the enhanced strategies recommend requiring universal indoor masking. (Id. ¶ 74; PSOF ¶ 74.)

As of May 2020, CFACC did not require detainees to wear masks inside their housing units but encouraged them to do so and educated them on the reasons to do so. (DKSOF ¶ 85.) All detainees were provided cloth face masks, with replacements available upon request, and were required to wear paper surgical masks when leaving their pods and going to other areas where social distancing is more difficult. (Id. ¶¶ 84-85, 87.) Detainee porters, kitchen, commissary, or laundry workers were also provided gloves and masks and other PPE as required by applicable guidelines. (Id. ¶ 90.)

Symptomatic or COVID-19 positive detainees in isolation were provided medical grade surgical masks and were required to wear masks when leaving their cells and while in their cells when speaking to medical staff. (Id. ¶¶ 88-89.) Prior to detainees' outside transports to an offsite hospital or medical clinic, staff were required to screen the detainees for COVID-19 by taking their temperatures and noting them on the transport orders. (Id. ¶ 95.) Those with temperatures of 100 degrees or higher would be escorted to medical immediately while wearing a paper mask. (Id.)

Front gate signs advised all visitors that they were required to wear a mask and that, if they did not have one, they were to social distance and obtain a mask in the lobby and put it on immediately; lobby door signs repeated these instructions. (Id. ¶¶ 92-93.)

After reviewing the May 3, 2022 CDC Guidance, CoreCivic approved a change from mandatory to voluntary masking for staff, visitors, and detainees based on the CDC's two-factor requirement that (1) the local COVID-19 community level is "low," and (2) the Warden and facility health-care staff agree that the facility-based risk factors support the change. (Id. ¶ 97.) After a CoreCivic facility moves to voluntary masking, CoreCivic requires it to monitor COVID-19 community levels daily and return to mandatory masking if the community level returns to medium or high. (Id. ¶ 98.) The facility must also have a mask distribution plan in place and communicate it to staff and detainees. (Id.)

On May 9, 2022, after determining in consultation with CAFCC medical staff that the CDC factors supported a change from mandatory to voluntary masking, Warden Kline sought and obtained USMS approval for this change. (Id. ¶ 99.) On June 30, 2022, based on increases in community and facility transmission, CAFCC returned to mandatory masking. (Id. ¶ 100.)

3. Enhanced Sanitation Procedures

As of May 2020, CAFCC was following the CDC's March 23, 2020 "Interim Guidance on Management of [COVID-19] in Correctional and Detention Facilities" ("Interim Guidance") for sanitation, which included providing a no-cost supply of soap to detainees to permit frequent handwashing, using household cleaners and EPA-registered disinfectants for cleaning common

areas, and increasing the number of staff and detainees trained and responsible for cleaning common areas. (Id. ¶¶ 101-104.) CAFCC also updated its facility housekeeping plan to comply with CDC guidance, adding instructions for safe and appropriate use of disinfectants and PPE in areas where the virus may be present. (Id. ¶ 106.) Detainees were also educated during town hall meetings on how to safely sanitize common room surfaces, such as telephones and kiosks. (Id. ¶ 107.) Defendants claim that detainees were also provided EPA-approved disinfectants, such as HDQC2, to sanitize the common room equipment before and after each use. (Id. ¶¶ 111, 113.) Plaintiffs dispute that they received these cleaning solutions, citing to declarations of the named representatives that, as of May 4, 2020, they only received a small amount of cleaning solution, which was not antibacterial, and when it ran out, they had to resort to using water only without appropriate wipes to clean phones before use. (PSOF ¶ 113.)

4. Screening and Health Assessments

In its Interim Guidance, the CDC recommended verbal screening and temperature checks for all incoming detainees as well as for all staff and facility visitors. (DKSOF ¶¶ 125-26.)

In March 2020, CoreCivic developed its first COVID-19 screening tool and has amended it as the CDC has identified new information and symptoms. (Id. ¶ 128.) During intake, facility medical staff conducted symptom screenings, vitals checks, including temperature and oxygen pulsometer checks, and asked chronic health questions. (DKSOF ¶ 135.) Also, on or about April 7, 2020, CAFCC initiated a High-Risk Detainee Plan, that outlined operational strategies to identify, monitor, and care for high-risk detainees. (Id. ¶ 135.) For a time, a list of high-risk detainees was provided to the Unit Management Chief to ensure continued monitoring and prompt treatment if these detainees were exposed or potentially exposed to COVID-19. (Id. ¶ 136.)

At intake, medical staff provided a fact sheet to detainees regarding the Moderna COVID-19 emergency use authorization vaccine, which included information about COVID-19, its symptoms, who should or should not get the vaccine, and the known results and side-effects of the vaccine at that time. (Id. ¶ 132; PSOF ¶ 132; Doc. 192 at 77-81.) If a detainee indicated he or she had already received a dose of the vaccine, medical staff would attempt to verify this using the Arizona State Immunization Information System (ASIIS) online portal for in-state detainees or would attempt to obtain records from a detainee's prior out of state facility. (Id. ¶ 141.) If a detainee could not document receiving a vaccine, CAFCC identified the detainee as unvaccinated. (Id. ¶ 142.) If a detainee had received only one dose of either the Pfizer or Moderna vaccine and wanted a second dose, medical staff would administer a second dose of the Moderna vaccine as close as possible to 28 days after the first dose. (Doc. 192-2 78.) For those who received a dose at intake, CAFCC staff provided a CDC vaccine card to the detainee. (DKSOF ¶ 143.) Those who declined a vaccine at intake were provided educational materials and informed how to request a vaccine. (Id. ¶ 144.)

5. Cohort/Quarantine Strategies

a. Intake Cohorts

The CDC initially recommended a 14-day quarantine of all new intakes in individual cells before introducing them into the general population, but the CDC's Interim Guidance alternatively recommended placing them into small groups (cohorts) where facilities lacked the space to house each new intake individually. (Id. ¶¶ 146-47.) Starting on March 19, 2020, CAFCC began cohorting new arrivals and returnees from outside transports for 14 days, and if none of them developed symptoms or tested positive for the virus during that time, the detainees would be released into the general population. (Id. ¶¶ 152-154.) Within 24 hours of being placed in a cohort, CAFCC detainees were swab tested for COVID-19, unless they arrived on a weekend, then they were swab tested the following Monday. (Id. ¶ 155; 192-2, Ex. 3 (Rose Decl.) ¶ 12.) Cohorted detainees were housed individually as much as possible or, if necessary, with a single cellmate from the same cohort, with signs posted on each cell indicating the cohort group number and the cohort's anticipated release date. (Id. ¶ 158.)

Because the parties do not differentiate between federal detainees and CAFCC detainees more generally, and all detainees are subject to the same policies, the Court uses the term CAFCC detainees unless it is clear the facts only apply to USMS detainees.

The Court may take judicial notice of information posted on official government websites. See Daniels-Hall v. Nat'l Educ. Ass'n, 629 F.3d 992, 998-999 (9th Cir. 2010); Fed. R. Evid. 201 (allowing a court to take judicial notice of a fact "not subject to reasonable dispute in that it is ... capable of accurate and ready determination by resort to sources whose accuracy cannot reasonably be questioned"). Because Plaintiffs have included the CDC's November 29, 2022 Guidance as an exhibit to their Response (Doc. 238 at 5-11), the Court will cite to this exhibit instead of the more general CDC website.

During the cohort period, the detainees received the same activities and opportunities as those in the general population, but they were only allowed out of cell with other members of their cohort; each cohort was put on a schedule to allow access to the dayroom; and the dayrooms and common areas were sanitized between use by each different group. (DKSOF ¶¶ 158-61, 166.) If, during the cohort period, a detainee displayed symptoms of COVID-19 or was confirmed positive, the cohort was quarantined, and the quarantine period restarted from that date. (DKSOF ¶ 156.)

The CDC's more recent February 10, 2022 Guidance reduced the duration of intake cohorts from 14 to 10 days, and following this, CAFCC shortened its cohort period to 10 days. (Id. ¶¶ 148, 157.) The CDC's May 3, 2022 Guidance for normal operations recommended either using a routine observation period (cohort) or testing all detainees at intake. (Id. ¶¶ 148-149; Doc. 201-7 at 7.) As of June 1, 2022, CAFCC no longer cohorts new intakes. (Id. ¶ 157.) Instead, effective July 19, 2022, all new CAFCC intakes are swabbed with a rapid test during intake. (DKSOF ¶ 155; Doc. 192-3, Ex. 7 (Jaramillo Decl.) ¶ 43.)

b. Quarantine Housing

Over time, the CDC has reduced the recommended quarantine period for individuals who have tested positive or had close contact with someone who tested positive for COVID-19 from 14 to 8 days. (Id. ¶¶ 181-82.) Quarantine detainees are generally housed individually but are sometimes placed with a cellmate if they are both confirmed positive or negative for COVID-19. (Id. ¶ 177.) The quarantined detainees are tested if they show symptoms and consent to a test, and all detainees on the same pod as those quarantined are screened daily for symptoms. (DKSOF ¶ 179.) The parties materially dispute whether close contacts of detainees who test positive are also offered tests. Defendants claim that they are, and Plaintiffs point to declaration evidence that CAFCC does not offer testing to close contacts outside the infected detainee's own cell. (DKSOF ¶ 178; PSOF ¶ 178.)

Plaintiffs dispute that all detainees on the pod are screened daily during quarantine. (PSOF ¶ 179.) They base this dispute on the expert opinion of Dr. Venters, who opines that CAFCC does not have adequate ways of tracking medically vulnerable detainees and speculates that this deficiency could be a problem during a large outbreak, making it difficult for CAFCC staff to prioritize who is at most need of special monitoring and protections. This opinion does not controvert Defendants' evidence that, during quarantine, CAFCC staff conduct daily symptoms checks of all detainees on the same pod.

c. Medical Isolation

CAFCC has three dedicated medical isolation pods. (DKSOF ¶ 192.) If a detainee

reports symptoms, he or she is moved immediately to medical isolation, where testing and monitoring start. (Id. ¶ 193.) Although CAFCC's protocols have changed with the CDC's changed guidance over time, currently, if the detainee tests negative, they are returned to the general population. (Id. ¶¶ 198-199.) If the detainee tests positive, they are isolated for 10 days. (Id. ¶¶ 193-194.) Isolated detainees receive daily COVID-19 symptoms screenings, including temperature and O2 saturation checks, and are educated to report any new symptoms to the pill call nurses, who conduct pill pass twice a day, or to the officer in the unit. (Id. ¶¶ 95-96.) CAFCC also has a 12-bed infirmary licensed by the Arizona Department of Health with 24-hour nursing coverage for higher acuity patients. (Id. ¶ 203.)

6. COVID-19 Testing

During normal operations, the CDC's May 3, 2022 Guidance recommends testing all incoming detainees at intake or implementing a routine observation period, and when Enhanced Protection Strategies are in place, also testing before transfer or release and before/after community visits. (Id. ¶ 205.) Effective July 19, 2022, all new CAFCC intakes are swabbed with a rapid test during the intake process. (Id. ¶ 155.) Also consistent with current CDC guidance all detainees are offered a COVID-19 test if they develop symptoms. (Id. ¶ 207.) Defendants claim that CAFCC tests all close contacts, but Plaintiffs present evidence that it only routinely tests the COVID-19 positive individual's cellmate. (Id. ¶ 206; PSOF ¶¶ 206, 174.) Consistent with USMS requirements, detainees also receive a rapid test if they are transferred to a different facility or transported to court. (DKSOF ¶¶ 209-210.)

If a detainee being transferred tests positive, the onboarding facility is notified and decides whether to continue the transfer. (Id. ¶ 211.) Similarly, if a detainee going to court or being transferred refuses a test, the receiving court or facility is notified and decides whether to continue with the court appearance or transfer. (Id.) Approximately 95% of CAFCC detainees are transferred to another facility and provided testing before transfer; the other 5% are released, and CAFCC is able to provide testing prior to release. (Id. ¶ 213.) If a detainee tests positive on release, CAFCC has no authority to hold them. So they notify the Pinal County Public Health Services District of the release and the detainee's last known address so it can follow up with the detainee; the detainee is also provided PPE prior to release. (DKSOF ¶ 213.)

Plaintiffs dispute that all detainees are offered a test prior to release, but the excerpt of the Rose Declaration, to which they cite in support, does not contain the cited pages. (PSOF ¶ 213.)

7. Staff Screening

Since the start of the pandemic, all persons entering CAFCC, whether employees, contractors, USMS or other government partner employees, attorneys, or visitors, are subject to screening as a prerequisite to entering the facility. (Id. ¶ 218.) Early in the pandemic, when an employee had been denied entry or reported a positive test or close contact with a confirmed COVID-19 positive individual, CAFCC performed a contact-tracing analysis, using it's surveillance system to document each close contact of the employee over the past 48 hours to identify any other employees or detainees who may need additional monitoring, testing, or other precautions to minimize the spread of COVID-19 in the facility. (Id. ¶ 222.) Although CAFCC discontinued using the facility surveillance system for this purpose towards the end of 2020, it conducts

contact-tracing by interviewing the infected employee about their contacts over the past 48 hours. (Id. ¶ 223.) Defendants claim that the employee is immediately sent home and required to see a healthcare provider for further screening and to obtain clearance prior to being admitted into the facility, but Plaintiffs present declaration evidence that employees are only required to wait five days before returning. (DKSOF ¶ 224; PSOF ¶ 224.)

Plaintiffs dispute that CAFCC continues to contact trace, but the excerpt of the Rose Declaration, to which they cite in support, does not contain the cited pages. (PSOF ¶ 223.)

8. COVID-19 Vaccines and Boosters

On January 22, 2021, CAFCC began offering the COVID-19 vaccine to detainees, with designated areas in each housing unit for detainees to get vaccinated and/or privately discuss their concerns about the vaccine with medical staff. (DKSOF ¶¶ 231-32.) All vaccination information is documented in the detainees' electronic health records, and if a detainee received the first dose of a two-dose vaccine, the second dose would be ordered and administered at the appropriate dose interval if the detainee remained at CAFCC. (Id. ¶ 233.) Prior to March 31, 2021, when vaccines were not widely available, CAFCC followed Pinal County Public Health Services District guidelines to prioritize detainees identified as vulnerable. (Id. ¶ 235.)

Effective March 31, 2021, vaccines and vaccine boosters are offered to all CAFCC detainees over eighteen without regard to whether they have any identified CDC risk factors. (Id. ¶ 236.) CAFCC currently uses the Moderna vaccine, which is provided by Pinal County. (Id. ¶ 240.) Since it began offering the COVID-19 vaccine to detainees, CAFCC has never run out of doses of the vaccine, which it orders regularly through the Arizona State Health Department online portal whenever the supply reaches or falls below 100 doses. (Id. ¶ 241.) For every order placed, CAFCC also receives supplies from the State, including syringes, alcohol swabs, face shields, and masks. (Id.)

When CAFCC started receiving the vaccine, it set vaccination target dates for each housing unit and conducted town hall meetings approximately 5 days prior to vaccinations in that unit to advise detainees that the vaccines are available, provide education on the vaccines, and give detainees an opportunity to ask questions and to consent to or refuse a vaccine. (Id. ¶ 243, 245.) Pre-town hall information sheets were also provided to detainees and were posted in each housing unit in English and Spanish. Town hall meetings were conducted in English and Spanish with handouts and language lines available for other languages, if needed. (Id. ¶¶ 244-246.)

Plaintiffs dispute that medical staff were at all meetings, but the excerpt of the Murray Declaration, to which they cite as stating the meetings were "done by security staff," does not contain the cited pages. (PSOF ¶ 245.)

As of March 1, 2022, 85 "vaccination events" were held in CAFCC housing units, and more than 860 detainees per month, for a total of 8,690 detainees were offered the COVID-19 vaccine in less than one year. (DKSOF ¶ 248.) Since then, no formal "vaccination events" have been scheduled since all detainees have been offered the vaccine, and it is offered to new arrivals during intake. (Id. ¶ 249.) Plaintiffs do not dispute these facts but present declaration evidence from Defendant Kline and CAFCC Complex Health Services Administrator K. Jaramillo, that detainees are not offered boosters on intake, even if they are determined to be eligible, although information on how to obtain a booster is posted and appears in a handbook. (PSOF ¶ 249.) To obtain a vaccine or booster, detainees may submit a medical request form to the medical department, or if they verbally request a vaccine from staff, they will be directed to submit a medical request form. (DKSOF ¶ 253.) Written requests are triaged within 24 hours by the Communicable and Infectious Disease (CID) nursing staff, and CAFCC nursing staff then have 72 hours to further review and schedule requests; the detainees name is placed in the vaccine log, which tracks when the vaccine or booster was requested and administered. (Id. ¶ 254.) A detainee cannot receive a vaccination or booster without first acknowledging receiving a fact sheet and signing a consent form. (Id. ¶ 260.) COVID-19 vaccines are also available to all CAFCC staff. (Id. ¶ 296.)

9. COVID-19 Antiviral Treatment

Where antiviral medications, such as Paxlovid and Molnupiravir, are clinically indicated, CAFCC has access to these medications through local pharmacies and therefore does not keep these medications in stock. (Id. ¶¶ 275-78.) CAFCC detainees must still consent to taking these medications, if prescribed, and always have the right to refuse COVID-19 tests, vaccinations, boosters, antiviral medications, or other therapies for COVID-19 symptoms or related illnesses. (Id. ¶ 278.)

10. COVID-19 Education

CAFCC complies with CDC guidelines recommending posting educational signage throughout the facility about COVID-19, and it posted educational materials throughout the facility and in all housing units about COVID-19 symptoms, vaccines, and boosters, what to do if you are sick, hand-washing, sanitation and cleanliness, mask use, steps to reduce exposure to COVID-19, social distancing, and how to report and to whom to report symptoms, which are updated as new information is obtained from the CDC. (Id. ¶¶ 279-281.) A document titled "Here's the Scoop" is posted throughout the facility and on the detainee tablet home screens with information about COVID-19 vaccines and boosters and how to request them, and detainees cannot access their tablets without acknowledging having read this information. (Id. ¶¶ 291-92.) Plaintiffs dispute, based on photographs taken in the facility on February 28, 2022, that any documents other than the "Here's the Scoop" poster were posted in the housing units, and they point out that the "Here's the Scoop" poster contains only logistical information regarding getting vaccinated, not educational information about the virus or the vaccine. (PSOF ¶¶ 281, 291; Doc. 192-2 at 64-65.)

As of May 2020, unit staff held town hall meetings to discuss any changes in protocols and procedures, such as when social visitation was cancelled and when sanitation schedules and/or mask requirements were updated. (DKSOF ¶ 282.) All unit staff were also instructed on COVID-19 symptoms and to alert medical staff if such symptoms were reported or observed. (Id. ¶ 288.) Detention staff are also educated in the normal course of operation how to administer emergency first aid, and medical staff and providers are available around the clock, either on site or on call. (Id. ¶ 289.)

11. Detainee Programming and Services

In the early days of the pandemic, programming was reduced, but not eliminated, to allow for social distancing. (Id. ¶ 297.) Since July 2021, in-person programming has returned to pre-pandemic levels, and recreation has largely gone unchanged due to the size of the recreation yards. (Id. ¶¶ 297-98.) All detainees have access to a wide variety of programming and classes, including mental health programming, self-help and job skills classes, and religious programs. (Id. ¶ 299.)

12. Court Services

CDC recommendations and Arizona court administrative orders have changed

over the course of the pandemic, with prior CDC guidance recommending alternatives to in-person court appearances, and courts cancelling in-person appearances and continuing civil and criminal trials set to begin before April 10, 2020. (Id. ¶¶ 303-304.) As of May 2020, CAFCC had not cancelled legal visitation, but non-contact visitation, like video teleconferencing (VTC) was encouraged, and the facility's VTC system was available Monday through Friday, 7:00 a.m. to 9:00 p.m. (Id. ¶ 305.) If an attorney requested a contact visit, the visitation area was sanitized before and after the visit. (Id. ¶ 306.) Detainees were also permitted to call their attorneys from their housing pods without the call being monitored or recorded if the recipient was designated an attorney. (Id. ¶ 307.) The VTC system is also used for court appearances, and at its highest point, CAFCC was facilitating 650-700 VTC appearances weekly. (Id. ¶ 308.)

13. COVID-19 Statistics

Between April 2020 and July 2022, a total of 44,703 USMS detainees cycled through CAFCC. (Id. ¶ 309.) A total of 1,782 of these detainees tested positive for COVID-19 while at CAFCC (560 in 2020, 516 in 2021, and 706 in 2022), meaning about 3.9% of USMS detainees who passed through CAFCC during that period tested positive for COVID-19 since testing became available. (Id.) During that period, 2,377, staff worked at CAFCC, with approximately 569 staff employed at CAFCC at any given time. (Id. ¶ 311.) Out of the 2,377 staff who worked at CAFCC during that period, 594 tested positive for COVID-19, thus about 2.5% of staff who passed through CAFCC tested positive since testing became available. (Id.)

Between January 22, 2021, when CAFCC began offering COVID-19 vaccines, and July 22, 2022, 13,089 detainees were offered a vaccine, including 9,967 USMS detainees. (Id. ¶ 314.) As of July 22, 2022, 1,700 USMS detainees had received the (single dose) Johnson & Johnson vaccine, 1,085 USMS detainees received the first dose of the (two-dose) Moderna vaccine, 957 received the second does of the Moderna vaccine, and 256 received boosters while at CAFCC. (Id. ¶¶ 314-16.) An additional 8,265 USMS detainees refused the vaccine. (Id. ¶ 316.)

It is not clear from Defendants' evidence whether any of the detainees who refused the vaccine at CAFCC had already been vaccinated elsewhere.

As of July 22, 2022, the USMS population at CAFCC was 3,724, and of those detainees, 10% became fully vaccinated while at CAFCC. (Id. ¶ 317.) According to Defendants, there is no reliable way to confirm whether new intakes are either partially or fully vaccinated, so the total number and percentage of fully vaccinated USMS detainees is likely higher than 10%. (Id.) Plaintiffs dispute that CAFCC is unable to confirm the vaccination status of new intakes, which Defendants elsewhere claim CAFCC staff attempt to do via the State's vaccination database or via the transfer records of new detainees, and Plaintiffs argue that, without this information, Defendants' claims that the percentage of USMS detainees who are fully vaccinated is higher than 10% are merely speculative. (PSOF ¶ 317.) As of July 22, 2022, 61% of CAFCC staff had received the COVID-19 vaccine. (DKSOF ¶ 318.) Since the start of the pandemic through April 20, 2022, two detainee deaths and five staff member deaths at CAFCC have been attributed to COVID-19, making the mortality rate among CAFCC detainees about 0.0015% (2/1332). By comparison, mortality rate estimates for COVID-19 infections are 1.2% in the U.S., 1.5% in Arizona, and 1.25% in Pinal County. (Id.) Defendants attribute the lower mortality rate at CAFCC to effective mitigation and healthcare strategies. (Id.) Plaintiffs dispute this claiming evidence suggests that the latter statistics are unreliable due to underreporting of COVID-19 cases in the community; Plaintiffs also dispute the reliability of CAFCC's official records attributing only two detainee deaths to COVID-19. (PSOF ¶¶ 312, 313.)

Defendants do not provide any data about the vaccination rate of non-USMS detainees at CAFCC.

It is not clear from Defendants' evidence whether this is only the percent of staff who were vaccinated at CAFCC or the total percent of staff vaccinated, either at CAFCC or elsewhere. It is also not clear whether this percentage includes staff who were partially vaccinated or only those who were fully vaccinated.

This estimate comes from Dr. Murray's declaration (Doc. 192-3, Ex. 6 (Murray Decl.) ¶ 134). Dr. Murray calculated this percentage based on a total of 1,332 detainees who tested positive for COVID-19 from the start of testing up to April 20, 2020. (Id.) Elsewhere, Defendants state that a total of 1,782 USMS detainees tested positive for COVID-19. (See DKSOF ¶ 309.) This discrepancy appears to be because the higher number includes at least two additional months of data, up to June 2022. (Id.) It is also not clear when Dr. Murray made this calculation or what available data he used to do so.

IV. Defendants' Motions for Summary Judgment

Defendant Kline and Federal Defendants argue they are entitled to summary judgment based on Plaintiffs' alleged failures to exhaust administrative remedies, mootness, and on the merits of their Fifth Amendment claim. (Docs. 192, 194.)

A. Exhaustion of Administrative Remedies

1. Legal Standard

Under the Prison Litigation Reform Act (PLRA), a prisoner must exhaust "available" administrative remedies before filing an action in federal court. See 42 U.S.C. § 1997e(a); Vaden v. Summerhill, 449 F.3d 1047, 1050 (9th Cir. 2006); Brown v. Valoff, 422 F.3d 926, 934-35 (9th Cir. 2005). The prisoner must complete the administrative review process in accordance with the applicable rules. See Woodford v. Ngo, 548 U.S. 81, 92, 126 S.Ct. 2378, 165 L.Ed.2d 368 (2006). Exhaustion is required for all suits about prison life, Porter v. Nussle, 534 U.S. 516, 523, 122 S.Ct. 983, 152 L.Ed.2d 12 (2002), regardless of the type of relief offered through the administrative process, Booth v. Churner, 532 U.S. 731, 741, 121 S.Ct. 1819, 149 L.Ed.2d 958 (2001).

The defendant bears the initial burden to show that there was an available administrative remedy and that the prisoner did not exhaust it. Albino v. Baca, 747 F.3d 1162, 1169, 1172 (9th Cir. 2014); see Brown, 422 F.3d at 936-37 (a defendant must demonstrate that applicable relief remained available in the grievance process). Once that showing is made, the burden shifts to the prisoner, who must either demonstrate that he, in fact, exhausted administrative remedies or "come forward with evidence showing that there is something in his particular case that made the existing and generally available administrative remedies effectively unavailable to him." Albino, 747 F.3d at 1172. The ultimate burden, however, rests with the defendant. Id. Summary judgment is appropriate if the undisputed evidence, viewed in the light most favorable to the prisoner, shows a failure to exhaust. Id. at 1166, 1168; see Fed. R. Civ. P. 56(a).

A class of prisoner-plaintiffs satisfies the PLRA's administrative exhaustion requirement through "vicarious exhaustion," i.e., when "one or more class members ha[s] exhausted his administrative remedies with respect to each claim

raised by the class." Chandler v. Crosby, 379 F.3d 1278, 1287 (11th Cir. 2004) (internal quotation marks and citations omitted). "[T]his rule advances the purpose of administrative exhaustion, which ... 'is to put the [administrative authority] on notice of all issues in contention and to allow the [authority] an opportunity to investigate those issues." " Id. (quoting Griffin v. Carlin, 755 F.2d 1516, 1531 (11th Cir. 1985)). It is therefore sufficient for class-wide exhaustion that at least one class member has exhausted each relevant claim, permitting the administrative entity an opportunity to resolve the alleged class-wide issues internally prior to court intervention. Chandler, 379 F.3d at 1287; cf. Oatis v. Crown Zellerbach Corp., 398 F.2d 496, 499 (5th Cir. 1968) ("[T]o require a multiplicity of separate, identical charges before the EEOC, filed against the same employer, as a prerequisite to relief through resort to the court would tend to frustrate our system of justice and order.").

If the defendants move for summary judgment for failure to exhaust and the evidence shows that the plaintiff did, in fact, exhaust all available administrative remedies, it is appropriate for the court to grant summary judgment sua sponte for the nonmovant. See Albino, 747 F.3d at 1176 (pro se prisoner did not cross-move for summary judgment on issue of exhaustion, but because he would have succeeded had he made such a motion, sua sponte grant of summary judgment was appropriate).

2. Facts Relevant to Exhaustion

a. CoreCivic/CAFCC Administrative Remedy Process

CoreCivic/CAFCC Policy 14-103 sets forth the administrative remedies available to federal detainees for complaints regarding facility conditions, treatment, and policies. (DKSOF ¶ 324.) This policy is included in the Detainee Handbook, which is provided to detainees during intake and is available to detainees upon request at the law library. (Id.) Detainees are given instructions on the grievance process during orientation and on an ongoing basis "as needed." (Id. ¶ 326.) Grievance forms are available in all the housing units, and for detainees in restrictive housing, in the indoor recreation enclosures, or from staff upon request. (Id. ¶ 327.) Detainees may seek assistance from a staff member or another detainee when completing a grievance form. (Id. ¶ 328.)

Plaintiffs dispute that grievance forms are always available (PSOF ¶ 327), but the evidence Plaintiffs cite either does not address the availability of grievance forms or is not specific enough to controvert these facts.

The grievance process consists of three steps: (1) informal resolution (optional), in which detainees are encouraged to resolve their issues informally with appropriate staff before filing a formal grievance, (2) formal grievance (required); and (3) appeal (required). (Id. ¶¶ 340-41.) If a detainee chooses to use the informal resolution process, he or she must submit an Informal Resolution Form 14-5A within seven calendar days of the incident giving rise to the complaint and must place the Informal Resolution Form (IRF) in the grievance box located in each housing unit. (Id. ¶ 242.) Absent unusual circumstances, the detainee will receive a response from the housing Unit Manager within ten calendar days of submission of the informal resolution. (Id. ¶ 343.) If unusual circumstances exist, the Unit Manager will provide written documentation to the detainee extending the response deadline. (Id.)

If a detainee is unsatisfied with the informal resolution process result or chooses to forgo that process, he or she may proceed to the formal grievance stage at any time while the informal grievance is still

pending or within 5 days of a response; if she bypasses the informal resolution stage, she must file a formal grievance within seven calendar days of the alleged incident. (Id. ¶¶ 345-46.) The detainee must complete page 1 of the Grievance Form and place it in the grievance mailbox in the housing unit. (Id. ¶ 347.) Unless a time extension has been granted, the detainee will receive a response to the formal grievance within ten calendar days of submission. (Id. ¶ 348.)

If a detainee is not satisfied with the formal grievance response, he or she must complete the Appeal section of the Grievance Form 14-5B and resubmit the grievance in the grievance mailbox within five calendar days of the response. (Id. ¶ 349.) The Grievance Officer must then forward the grievance appeal to the Warden, and the Warden will have ten calendar days to issue a final response. (Id. ¶ 350.) Unless unusual circumstances are present, the total time for the grievance process from the filing of a Grievance Form to a final Appeal decision is 27 days. (Id. ¶ 351.)

Detainees must submit their grievances in their housing unit's grievance mailbox, which is checked each night, except Saturdays, Sundays, and holidays. (Id. ¶ 335; PSOF ¶ 335.) Utility staff must collect the grievances and place them in a locked drop box the same night for the Grievance Coordinator to pick up the following morning, Monday through Friday. (DKSOF ¶ 335.)

If the subject matter of a grievance is such that compliance with the regular timeframes would create a risk of personal injury, the detainee may request that the grievance be considered an emergency grievance by filling out the Grievance Form and placing it a sealed envelope with "Emergency Grievance" on the outside. (Id. ¶¶ 353-55.) Emergency grievances must be placed in the grievance box or, if after hours or on weekends, given directly to the Unit Manager or Shift Supervisor and delivered to the designated Administrative Duty Officer, who will review it and determine if it is an emergency. (DKOF ¶ 356.) If it is determined to be an emergency, the grievance must be resolved and responded to within 24 hours of receipt. (Id.)

Upon receipt by staff, all informal resolutions, grievances, and appeals must be entered into an electronic database called CoreCivic Apps, to include the detainee's name, number, and housing assignment and the date, category of the complaint, and the type of form used. (Id. ¶ 329.) This information must also be entered into a Grievance Log, which is in Excel format. The CoreCivic Apps database is searchable by name or detainee number and allows the user to view every submitted grievance that was logged. (Id. ¶ 331.) Grievance forms are in triplicate with one copy for the detainee; one for the detainee's institutional file, and one for CoreCivic. (Id. ¶ 333.)

Plaintiffs do not dispute that these are the required procedures, but they dispute that this was done in their cases. (PSOF ¶¶ 329-30.)

b. Plaintiffs' Grievance Histories

CAFCC Grievance Coordinator A. Partain reviewed the grievance files in CoreCivic Apps and the Grievance Log for the named Plaintiffs and found that only James Tyler Ciecierski submitted an IRF about CAFCC's COVID-19 protocols, and only Marvin Lee Enos submitted a Formal Grievance regarding the same. (Id. ¶¶ 358-59; Doc. 16-8 (Partain Decl.) ¶¶ 1, 33-35.)

i. Mr. Ciecierski's Grievances

Plaintiff Ciecierski was booked into CAFCC on February 27, 2020 (DKSOF ¶ 322), and Plaintiffs filed this action on May 8, 2020. (Doc. 1.) Four days prior to

initiating this action, on May 4, 2020, Mr. Ciecierski submitted an IRF, which was assigned No. W-US-2020-0487 and entered on the Grievance Log, in which he alleged that, due to his severe asthma and housing conditions that did not allow social distancing, he could die if he contracted COVID-19. (Id. ¶¶ 360, 362.) He requested a single cell and hand sanitizer. (Id. ¶ 360.)

On May 8, 2020, Unit Manager L. Meyer responded that CAFCC was following all CDC guidelines for sanitation and was providing masks and that no housing change would be made at that time. (Id. ¶ 361.) Unit Manager Meyer encouraged Mr. Ciecierski to notify staff immediately if he began to display any symptoms, in which case he would be seen by medical. (Id.) Mr. Ciecierski noted on the IRF that he wanted to appeal, but there is no record he ever filed a Formal Grievance or any other Informal Resolutions related to COVID-19 prior to Plaintiffs filing their Complaint on May 8, 2020. (Id. ¶¶ 363, 365.)

In his Declaration, Mr. Ciecierski states that he filed a grievance around April 15, 2020, asking for conditions that would reduce the risk of COVID-19 in his pod, but he never received a response, so he filed another grievance on April 30, 2020, but as of May 4, 2020, when he executed his declaration, he had not received a response. (PSOF ¶ 366.) CAFCC has no record that Mr. Ciecierski filed any grievance forms around April 15, 2020 or on April 30, 2020. (DKSOF ¶ 365.)

ii. Mr. Enos' Grievances

Plaintiff Enos was booked into CAFCC on August 6, 2019. (DKSOF ¶ 322.) On April 20, 2020, he submitted a Grievance Form, No. W-US-2020-0402, as an "emergency grievance," alleging that the facility was not taking proper COVID-19 precautions, such as providing hand sanitizer to detainees, face masks to staff, or cleaning supplies for detainees to clean their cells; detainees were unable to socially distance and porters were not cleaning the day room as often. (Id. ¶ 367; PSOF ¶ 367.) He alleged that he believed his life was in danger due to the threat of contracting COVID-19. (Id.) According to his declaration in this action, Mr. Enos also filed an emergency grievance regarding the same issues on April 22, 2022. (PSOF ¶ 371.)

On April 27, 2020, Unit Manager Fernandez responded that CAFCC had several precautions in place for staff and detainees to clean and sanitize, each cell had an assigned spray bottle, the facility was following CDC guidelines pertaining to sanitation, masks had been given to all detainees, staff would wear masks, and the supervisors in the units would adjust porter schedules to allow for day room and shower sanitation and cell cleaning. (DKSOF ¶ 368.) There is no record that Mr. Enos ever appealed this response. (Id. ¶ 370.) According to Mr. Enos, grievance forms were rarely available. (Id.)

iii. Ms. Peuplie's Grievances

Plaintiff Peuplie was booked into CAFCC on February 27, 2020. (Id. ¶ 321.) CAFCC has no record Ms. Peuplie ever submitted any grievances about the facility's COVID-19 response protocols while at CAFCC or any other CoreCivic-operated facility prior to Plaintiffs filing their Complaint in this action on May 8, 2020. (Id. ¶¶ 372-74.) According to her declaration, Ms. Peuplie filed emergency grievances stating her concerns that she would contract COVID-19 around April 22, 2020 and on April 30, 2020, but as of May 4, 2020, she had not received any response. (PSOF ¶ 371.) Ms. Peuplie stated that she gave her April 30, 2020 emergency grievance directly to staff and asked about the status of her first emergency grievance, and the staff member replied that they receive about 400 grievances a day and stated, "we'll get to it whenever we get to it." (Id. ¶ 373.) 3. Discussion

Defendants have met their initial burden of showing that administrative remedies were available to Plaintiffs to raise concerns about CAFCC's COVID-19 prevention protocols, and no named Plaintiff exhausted those remedies before filing this action. Grievance Coordinator Partain's search of CAFCC grievance records showed that Mr. Ciecierski submitted IRF No. W-US-2020-0487 regarding his asthma and concerns of contracting COVID-19 while housed without social distancing, and on May 4, 2020, he received a response, denying his request for a single cell, but he did not file a Formal Grievance. Additionally, Mr. Enos submitted Grievance Form No. W-US-2020-0402 regarding his concerns about contracting COVID-19 on April 20, 2020, and he received a response on April 27, 2020, which he did not appeal. Finally, Grievance Coordinator Partain searched CAFCC's electronic database and Grievance Log and found no record that Ms. Peuplie filed any COVID-19 grievances before Plaintiffs filed this action.

Based on this showing, the burden shifts to Plaintiffs to come forth with evidence that they did, in fact, exhaust their administrative remedies or that "something in [their] particular case[s] ... made the existing and generally available administrative remedies effectively unavailable to [the]m." Albino, 747 F.3d at 1172.

Plaintiffs have made this showing at least as to Ms. Peuplie. According to her declaration, Ms. Peuplie submitted two emergency grievances stating her concerns about contracting COVID-19: first, on April 22, 2020, and then on April 30, 2020, when she handed her emergency grievance directly to staff and requested to know the status of her prior emergency grievance because she had not received a response. Even if CAFCC staff chose not to treat Ms. Peuplie's emergency grievance as an emergency requiring a 24-hour response, according to policy, Ms. Peuplie should have received a response to her first emergency grievance within 10 days, or by May 2, 2008, two days after she spoke to the staff member, but as of May 4, 2020, when she executed her declaration, she still had not received a response.

There is also no evidence that staff required additional time to respond to Ms. Peuplie's emergency grievance or that, if this was the case, anyone informed her of an extension to the normal timeframes for a response, and Defendants do not point to any provision in CAFCC's grievance policies that permit or instruct detainees to move to the next level of the grievance process if they do not receive a timely response. Additionally, the policy requires the grievant to fill out the appeal section of the grievance form and it is not clear how the grievant would be able to complete this step without first receiving a response. Thus, without a timely response, Ms. Peuplie's only recourse for her urgent COVID-19 concerns was to submit another emergency grievance, which she did on April 30, 2020. This time, she spoke to the staff member who took her emergency grievance, but instead of assuring Ms. Peuplie that she would receive a response to her emergency grievance within 24-hours, or even within 10 days if her grievance was determined not to be an emergency, the staff member told her CAFCC received 400 grievances a day and, "we'll get to it whenever we get to it." (PSOF ¶ 373.)

Four days later, when she executed her declaration, Ms. Peuplie still had not received a response, to either of her grievances, and based on what staff told her, she had no reason to expect she would receive a response anytime soon, even if she continued to file emergency grievances. See Brown, 422 F.3d at 937 ("information provided the prisoner is pertinent

because it informs our determination of whether relief was, as a practical matter, 'available.'") (internal citation omitted). The Supreme Court has recognized that administrative remedies are effectively unavailable when, despite what the regulations may state, the grievance process "operates as simple dead end—with officers unable or consistently unwilling to provide any relief to aggrieved inmates." Ross v. Blake, 578 U.S. 632, 136 S. Ct. 1850, 1859, 195 L.Ed.2d 117 (2016). Plaintiffs have created a question of fact that administrative remedies were effectively unavailable in this instance, and Ms. Peuplie's failure to exhaust should therefore be excused. For class-wide exhaustion purposes, it is enough that Plaintiffs can make this showing as to at least one class member—they need not do more to demonstrate exhaustion or a lack of available administrative remedies to proceed as a class. See Chandler, 379 F.3d at 1287 ("requiring all class members to exhaust their administrative remedies, 'could impose an intolerable burden upon the inmate complaint review system'" and could make it "extraordinarily difficult" for all class members to exhaust where the composition of the class is subject to constant change beyond the class members control) (quoting Jones 'El v. Berge, 172 F.Supp.2d 1128, 1133 (W.D. Wis. 2001)). The Court will deny summary judgment to Defendants on exhaustion.

B. Mootness

1. Legal Standard

Under Article III of the Constitution, the jurisdiction of a federal court depends on the existence of a "case or controversy"; without a case or controversy, a claim is moot. Pub. Util. Comm'n of State of Cal. v. FERC, 100 F.3d 1451, 1458 (9th Cir. 1996). A claim is considered moot if it is no longer a present and live controversy or if no effective relief can be granted. Mitchell v. Dupnik, 75 F.3d 517, 527-28 (9th Cir. 1996). When a question before the court has been mooted by changes in circumstances after the complaint is filed, there is no justiciable controversy. Flast v. Cohen, 392 U.S. 83, 95, 88 S.Ct. 1942, 20 L.Ed.2d 947 (1968).

Questions of mootness regarding injunctions are viewed "in light of the present circumstances." Id. at 528. "[A] suit for injunctive relief is normally moot upon the termination of the conduct at issue." Demery v. Arpaio, 378 F.3d 1020, 1025-26 (9th Cir. 2004). Thus, if a prisoner is no longer subjected to prison officials' allegedly unlawful activity, the complaint for injunctive relief becomes moot. Wiggins v. Rushen, 760 F.2d 1009, 1011 (9th Cir. 1985). A case becomes moot only "if subsequent events ma[ke] it absolutely clear that the allegedly wrongful behavior could not reasonably be expected to recur." Friends of the Earth, Inc. v. Laidlaw Envtl. Servs. (TOC), Inc., 528 U.S. 167, 189, 120 S.Ct. 693, 145 L.Ed.2d 610 (2000) (internal quotation marks and citations omitted) (emphasis added).

2. Discussion

a. Releases of Named Class Representatives

Since Plaintiffs initiated this action, all three named representatives of the detainee class have been released or transferred to other facilities. (See Doc. 194 at 15; DKSOF ¶¶ 31-323.) Defendants argue that this, alone, moots Plaintiffs' class-wide claims. (Doc. 194 at 15.) The Court rejected a similar argument when it granted Plaintiffs' Motion for Class Certification despite the need for a change in class representatives at that time, stating that,

In the incarceration context, in which the duration of the individual class representatives' time in custody is by nature transitory, "the termination of a class representative's claim does not

moot the claims of the unnamed members of the class." Cnty. of Riverside v. McLaughlin, 500 U.S. 44, 51, 111 S.Ct. 1661, 114 L.Ed.2d 49 (1991) (quoting Gerstein v. Pugh, 420 U.S. 103, 110 n.11 [, 95 S.Ct. 854, 43 L.Ed.2d 54] (1975)). In Gerstein, the Supreme Court noted ... that "pretrial detention is by nature temporary" and could be "ended at any time by release on recognizance, dismissal of the charges, or a guilty plea, as well as by acquittal or conviction after trial," making it "by no means certain that any given individual, named as plaintiff, would be in pretrial custody long enough for a district judge to certify the class." 420 U.S. at 110 n.11 [, 95 S.Ct. 854].

(Doc. 69 at 18.)

The Court went on to find, as also applies here, that,

if a named Plaintiff's circumstances materially change and, as a result, his or her interests diverge from the remainder of the class or he or she is otherwise no longer personally interested in or capable of continuing to represent that class, other unnamed class members may be appointed to serve in his or her place, allowing for continued adequate representation by those who remain in custody and continue to share the same interests as the respective class.

(Id. at 18 (citing Gerstein, 420 U.S. at 110 n.11, 95 S.Ct. 854; Sosna v. Iowa, 419 U.S. 393, 402 n.11, 95 S.Ct. 553, 42 L.Ed.2d 532 (1975); Schall v. Martin, 467 U.S. 253, 256 n. 3, 104 S.Ct. 2403, 81 L.Ed.2d 207 (1984); Cnty. of Riverside, 500 U.S. at 52, 111 S.Ct. 1661); Doc. 89 at 6 n.2.)

Defendants' reliance on cases dismissing as moot individual conditions-of-confinement claims and habeas petitions when the plaintiffs/petitioners in those cases were released (see Doc. 194 at 15) does not compel a different conclusion here. Such cases simply do not apply in the class action context where the plaintiff class may continue to have viable class-wide claims even after the class representatives' situations materially change. Accordingly, Plaintiffs' claims are not moot simply because the named representatives have been released, and the Court will deny summary judgment to Defendants on this ground. Cnty. of Riverside, 500 U.S. at 51, 111 S.Ct. 1661; Gerstein, 420 U.S. at 110 n.11, 95 S.Ct. 854. If this case proceeds to trial, Plaintiffs will be permitted to substitute new named Plaintiffs at that time.

b. Change in Pandemic

Defendants next argue that changes in the pandemic and the widespread availability of COVID-19 vaccines moot Plaintiffs' claims. (Doc. 194 at 15.) Defendants rely, in part, on Martinez v. CoreCivic, a detainee class action lawsuit for habeas and injunctive and declaratory relief, in which the district court opined that

every time a staff member, or pre-trial detainee, or prisoner is vaccinated, the overall risk of outbreak at CCCC decreases. Approaching this issue pragmatically, rather than through a clouded political lens, the vaccine must smother all attempts by prisoners or pre-trial detainees to request COVID-19-related relief based upon the theory that the risk of infection violates the constitution; persons in custody who refuse the vaccine are now imperiled solely as a result of their own free will and not because a detention center allegedly offended the Fifth, Eighth, and Fourteenth Amendments by failing to sufficiently implement prophylactic measures.

2021 WL 2550319, No. CV 20-1309 WJ/CG, at *8 (D.N.M. June 22, 2021).

Defendants point to evidence that the COVID-19 Omicron variant is now the dominant variant in the United States and that, while Omicron spreads more rapidly

than prior variants, current vaccines are effective at protecting against Omicron, which generally causes less severe disease. (Id. at 16; DKSOF ¶¶ 26-28.) Defendants also argue that, due to the undisputed availability of vaccines to CAFCC detainees, Plaintiffs—like the class members in Martinez—have either reduced their risks of infection through vaccination or, by not getting vaccinated, accept those risks. (Doc. 194 at 16-17.) Defendants assert that the risk to any class members who have already contracted COVID-19 and recovered or who had asymptomatic COVID-19 that did not show up on tests is significantly less now than when Plaintiffs filed this action, particularly if these detainees have received the vaccine. (Doc. 194 at 17 (citing U.S. v. Bolton, 2021 WL 4812971, at *3 (C.D. Ill. Oct. 15, 2021) (finding inmate's "prior asymptomatic infection and subsequent vaccination make it unlikely that he will contract COVID-19 again or suffer severe complications if he does."); U.S. v. Stone, 2021 WL 4343439, at *3 (W.D. Ky. Sept. 23, 2021) ("A prior positive Covid-19 test reduces Stone's medical concerns about remaining in prison.")).)

Plaintiffs argue that Defendants fail to account for medically vulnerable class members with underlying conditions that place them at high risk of serious illness or death from COVID-19. (Doc. 200 at 7.) They point to evidence that medically vulnerable people may still develop severe disease, need hospitalization, and potentially die from exposure to Omicron. (Id.) They also argue that, even with vaccines, class members are still subject to unsafe conditions of confinement, and they claim without discussion that "serious failures in policies and practices by the Defendants have kept these medical advances from large numbers of class members." (Id. at 5-7.) Plaintiffs refer to CDC guidance stating that, even with vaccines, people in congregate settings require added prevention in the event of a facility outbreak. (Id. at 6.) They further point to the evidence that, as of July 22, 2022, only 10% of class members were fully vaccinated while at CAFCC, which they attribute to "Defendants' flawed policies around vaccination." (Id.) Plaintiffs also point to evidence that Defendants have not administered a single treatment of Paxlovid or other antiviral to any of the 1,782 detainees at CAFCC who tested positive for COVID-19 as of July 22, 2022. They assert that this shows their claims are not moot. (Id.)

Plaintiffs' arguments are mostly conclusory and unsupported. For purposes of mootness, however, Defendants' burden is high: they must show there is no remaining relief the court can order. See Halet v. Wend Inv. Co., 672 F.2d 1305, 1308 (9th Cir. 1982) ("The defendant bears a heavy burden to demonstrate mootness"); Lasar v. Ford Motor Co., 399 F.3d 1101, 1108 (9th Cir. 2005) ("To determine whether a case is moot, a court must ask whether a change in the circumstances existing at the beginning of the litigation has 'forestalled any occasion for meaningful relief' that the court could grant") (internal citation omitted). Thus, Plaintiffs need not show they will prevail on the merits of their claims, only that there is a remaining case or controversy and, if they prevail, there is a potential for the Court to order at least some relief.

At a minimum, and as fully discussed below, there are genuine issues of material fact about some of Defendants' COVID-19 response measures, which, if shown to rise to the level of a Fifth Amendment violation, entitle Plaintiffs to prospective injunctive relief.

Accordingly, the Court will deny summary judgment to Defendants on mootness grounds. C. The Merits

1. Fifth Amendment Legal Standard

The Fifth Amendment's Due Process Clause prohibits the federal government from depriving "any 'person ... of ... liberty ... without due process of law,'" and its protections extend "to all 'persons' within the United States." Zadvydas v. Davis, 533 U.S. 678, 690, 693, 121 S.Ct. 2491, 150 L.Ed.2d 653 (2001). Freedom from physical restraint falls at the core of the liberty interest protected from arbitrary governmental action by the Due Process Clause. Youngberg v. Romeo, 457 U.S. 307, 316, 102 S.Ct. 2452, 73 L.Ed.2d 28 (1982).

The government deprives an individual of this substantive liberty interest without due process when it restrains his "freedom to act on his own behalf—through incarceration, institutionalization, or other similar restraint of personal liberty," thereby "render[ing] him unable to care for himself, and at the same time fails to provide for his basic human needs—e.g., food, clothing, shelter, medical care, and reasonable safety." DeShaney v. Winnebago County Dept. of Social Services, 489 U.S. 189, 200, 109 S.Ct. 998, 103 L.Ed.2d 249 (1989); see also Alvarez-Machain v. United States, 107 F.3d 696, 701 (9th Cir. 1996) ("Pretrial detainees are entitled to 'adequate food, clothing, shelter, sanitation, medical care, and personal safety.'") (quoting Hoptowit v. Ray, 682 F.2d 1237, 1246 (9th Cir. 1982)).

To support a claim against a government official in his/her official capacity or against a private entity performing a traditional public function, such as providing medical care to prisoners, a plaintiff must show that his constitutional rights were violated under a policy, decision, or custom promulgated or endorsed by the private entity. See Tsao v. Desert Palace, Inc., 698 F.3d 1128, 1138-39 (9th Cir. 2012) (extending the "official policy" requirement for municipal liability under Monell v. Dep't of Soc. Servs., 436 U.S. 658, 691, 98 S.Ct. 2018, 56 L.Ed.2d 611 (1978), to private entities acting under color of law). Under Monell, a plaintiff must show: (1) he suffered a constitutional injury; (2) the entity had a policy or custom; (3) the policy or custom amounted to [reckless disregard] to the plaintiff's constitutional right; and (4) the policy or custom was the moving force behind the constitutional injury. See Monell, 436 U.S. at 691-94, 98 S.Ct. 2018; Mabe v. San Bernardino Cnty., Dep't of Pub. Soc. Servs., 237 F.3d 1101, 1110-11 (9th Cir. 2001).

2. Discussion

a. Constitutional Violation

The government or private entity is found to have violated its constitutional duty under the Due Process Clause to provide a detainee "conditions of reasonable health and safety" when:

(i) [It] made an intentional decision with respect to the conditions under which the plaintiff was confined;
(ii) those conditions put the plaintiff at substantial risk of suffering serious harm;
(iii) the [government or private entity] did not take reasonable available measures to abate that risk, even though a reasonable official in the circumstances would have appreciated the high degree of risk involved ...; and
(iv) by not taking such measures, the [government or private entity] caused the plaintiff's injuries.

Roman, 977 F.3d at 943 (alternations in original) (quoting Gordon v. County of Orange, 888 F.3d 1118, 1125 (9th Cir. 2018) (discussing the "objective deliberate indifference standard")).

It is undisputed that based on CDC guidance, Defendants (1) made intentional

decisions on the conditions under which USMS detainees were confined at CAFCC. From the start of the COVID-19 pandemic, Federal Defendants made intentional decisions on what to require of CAFCC, and CoreCivic/CAFCC implemented numerous policies and practices for how to respond to the pandemic. Given that 1,782 CAFCC detainees tested positive and two CAFCC detainees died from COVID-19 since the start of the pandemic, there are also genuine issues of material fact that (2) the conditions of confinement at CAFCC put Plaintiffs at substantial risk of serious harm.

Finding Plaintiffs suffered a constitutional violation rests on whether Plaintiffs can show that (3) Defendants failed to take reasonable available measures to avert the risk of harm, even though reasonable officials in the circumstances would have appreciated the high degree of risk involved, and that (4) by failing to respond reasonably to the risk, Defendants caused an "imminent" danger to Plaintiffs' health and safety. See Roman, 977 F.3d at 943 ("To satisfy the fourth element, a plaintiff need only prove a 'sufficiently imminent danger[],' because a 'remedy for unsafe conditions need not await a tragic event.'") (alternation in original) (quoting Helling v. McKinney, 509 U.S. 25, 33-34, 113 S.Ct. 2475, 125 L.Ed.2d 22 (1993)).

To show that Defendants failed to take reasonable available measures to abate the risk of harm, "the conduct must be objectively unreasonable, a test that will necessarily 'turn[] on the facts and circumstances of each particular case.'" Castro v. County of Los Angeles, 833 F.3d 1060, 1071 (9th Cir. 2016) (en banc) (alteration in original) (quoting Kingsley v. Hendrickson, 576 U.S. 389, 397, 135 S.Ct. 2466, 192 L.Ed.2d 416 (2015)). Objective unreasonableness is "more than negligence but less than subjective intent—something akin to reckless disregard"; "mere lack of due care" is not enough. Gordon, 888 F.3d at 1125 (quoting Castro, 833 F.3d at 1071).

Defendants have made an initial showing that they took reasonable available measures to abate the risk of harm to Plaintiffs of contracting COVID-19 while detained at CAFCC. Federal Defendants have shown they require CAFCC to comply with Federal Performance Based Detention Standards, all state and local laws, regulations, and court orders, and, more specifically, to follow COVID-19 CDC guidance. (FDSOF ¶¶ 3-6.) Federal Defendants conducted a QAR audit of CAFCC in August 2020 and determined the facility was following applicable CDC protocols at that time. (Id. ¶¶ 7-9.) Additionally, Federal Defendants joined in Defendant Kline's Motion and Statement of Facts regarding the responsive measures CoreCivic/CAFCC has taken since the start of the pandemic.

Defendant Kline has shown that, from the start of the pandemic, CoreCivic created a Facility Support Center, developed company-wide and facility-specific protocols based on CDC guidance and the recommendations of infectious disease specialists. They established regular communications between facility and supervisory staff to monitor, update, and adapt operational responses to COVID-19 based on changes in CDC guidance. (DKSOF ¶¶ 31-47.) CAFCC also implemented policies and practices for numerous protective measures, including social distancing in the housing units and recreation yards; masking and PPE use; enhanced sanitation; cohorting or testing new arrivals at intake; regular medical rounds and symptoms checks; quarantines and medical isolation for those who test positive or have symptoms; and screening staff and visitors upon entry to the facility. Since the development of the vaccine, CAFCC has offered COVID-19 vaccines

to all existing and incoming detainees. Taken together, these efforts are enough to initially show that Defendants have taken reasonable available measures to abate the risks to Plaintiffs from COVID-19 of which reasonable officials would have known and have not recklessly disregarded those risks.

Now, the burden shifts to Plaintiffs to create a genuine issue of material fact that Defendants failed to take reasonable available measures to mitigate the risk to Plaintiffs of contracting COVID-19 and of thereby suffering serious harm or an imminent threat of serious harm, though reasonable officials would have appreciated the risk. Plaintiffs argue several ways in which Defendants responses have been objectively unreasonable. Plaintiffs assert that though CAFCC's vaccination rate remains extremely low, Defendants have not implemented effective strategies for identifying immunocompromised detainees who should be targeted for the vaccine, their educational materials are ineffective, they do not offer boosters to booster-eligible individuals on intake, and they do not track or inform detainees of when they are eligible for a booster. (Doc. 200 at 17-21.) Plaintiffs also argue that Defendants' failures to follow the CDC's enhanced protection strategies for intake cohorts is unreasonable where the vaccination level at CAFCC remains low and turnover in the facility is high. (Id. at 22-25.) Finally, they argue that it is objectively unreasonable not to stock or administer antiviral therapies for those who test positive. (Id. at 25-27.)

i. Vaccination Policies

As stated in Defendants' Statement of Facts, CAFCC's 10% vaccination rate pertains to the percentage of the USMS detainee population who had become fully vaccinated while at CAFCC as of July 22, 2022. (DKSOF ¶ 317.) This figure is not useful because it fails to account for any USMS detainees who had already been fully vaccinated prior to entering the facility or those who became partially vaccinated at CAFCC but were released or transferred before receiving a second dose of the two-dose vaccine. In his deposition, defense expert Dr. Murray testified that, due to the transient nature of the detainee population, the vaccination rate at CAFCC continually fluctuates, and based on his discussions with medical staff, is generally around 16 to 30 percent, which Dr. Murray still described as "low." (Doc. 200 at 19; Doc. 201-1 (Murray Dep.) at 34:13-23.)

In comparison, Plaintiffs point to published vaccination rates of 80% in the Arizona Department of Corrections, Rehabilitation, and Reentry (ADCRR) and 81% in California's prison system. (Doc. 200 at 16-17.) They argue that CAFCC's vaccination rate falls "far below other, comparable rates" and that this "flows from missteps in CAFCC's vaccination program." (Id.) To elaborate, Plaintiffs rely on the opinion of Plaintiffs' expert Dr. Venters that, to increase COVID-19 vaccinations, CAFCC medical staff should schedule individual outreach appointments with high-risk detainees to attempt to increase vaccinations among the most vulnerable. (Id. at 17.) Plaintiffs cite to a journal article stating such outreach efforts increased vaccination acceptance rates in the California prison system, and they cite to Dr. Venter's declaration that the BOP's implementation of his recommendation of one-on-one outreach to high-risk unvaccinated prisoners

These figures do not present an apt comparison because prisons do not have the same inherently high turnover rate of pretrial detention facilities that makes it more difficult to fully vaccinate all detainees who come through the facility. Nonetheless, Defendants do not dispute that CAFCC's vaccination rate is extremely low or cite to any comparable rates at other pre-trial detention facilities.

at the BOP's Lompoc facility resulted in more high-risk prisoners getting questions answered and getting vaccinated. (Id. at 17; Doc. 203, Venters Decl. ¶ 48.)

Plaintiffs argue that CAFCC does not have an adequate system in place for identifying high-risk or immunocompromised people, whom the CDC recommends should receive more boosters than the general population. (Doc. 200 at 18.) They reference CAFCC Clinical Supervisor C. Rose's testimony that CAFCC used to, but no longer maintains a "list" of immunocompromised individuals at the facility because doing so became too burdensome. (Id. at 18-19; Doc. 201-1 (Rose Dep.) at 10:13-11:21.) Rose testified the medical director treats patients and reviews their charts and has discretion to recommend an immunocompromised person for a third primary dose of the vaccine, and to Rose's knowledge, he did so for at least one patient. (Rose Dep. at 10:13-11:21.) Rose did not identify any other means CAFCC uses to track and recommend additional vaccines to immunocompromised detainees other than those patients potentially being on the "radar" of the medical director. (Id.)

Plaintiffs also argue that CAFCC does not use appropriate educational materials, arguing that official vaccine fact sheets given at intake and CAFCC's "Here's the Scoop" poster, which contains only logistical information about how to get the vaccine, not educational information about the vaccine, are not designed to increase vaccine uptake. (Doc. 200 at 18-19, nn.16, 17.) Plaintiffs cite to Dr. Venters' recommendation that CAFCC should improve its educational efforts with materials written with an incarcerated audience in mind, such as those developed by AMEND, a project at the University of California which prepared materials in English and Spanish in collaboration with incarcerated and formerly incarcerated people. (Id.; Doc. 203, Venters Decl. ¶ 56.d.) Dr. Venters also recommended more uniform placement of such materials throughout the facility. (Id.)

Last, Plaintiffs argue that Defendants' booster policies are inadequate. (Doc. 200 at 20.) Plaintiffs cite to Defendants' evidence that, between April 2020 and July 2022, CAFCC administered 256 boosters, which is a "miniscule fraction of the '44,703 USMS detainees [who] have cycled through CAFCC,' ... and a small fraction even when compared against the woefully small group of 2,785 people who have received their initial dose at CAFCC." (Id.; citing DKSOF ¶¶ 309, 315.) Plaintiffs retort that this low rate is due, in part, to CAFCC's failures to offer boosters to incoming detainees even when their intake responses show they are eligible for one. Nor do medical staff include notations in CAFCC's electronic medical records system of the date someone is booster eligible. (Doc. 200 at 20.) They argue that it is unreasonable in the incarceration context, where individuals do not have access to their own medical records, to expect detainees to track their own eligibility and request boosters. For example, they note that it is a long-established practice for practitioners to notify incarcerated individuals when they are eligible for medical procedures, such as pneumovax and shingles vaccines. (Id.) In support, Plaintiffs reference Defense expert, Dr. Murray, who testified that the correctional facilities in Texas regularly notify people when they become eligible for an annual TB test and take them to be tested. (Id. at 21.) Plaintiffs also rely on Dr. Venter's statements in his declaration that:

[s]ome of the most basic functions of correctional health departments involve scheduling healthcare measures after particular time intervals, even when this healthcare might not be scheduled in this way in the community. For example, in carceral settings, tuberculosis tests

are recommended on an annual interval. Correctional healthcare systems generally take affirmative efforts to schedule these tests after a year has passed, rather than waiting for individual detained people to request them. Correctional healthcare systems also generally perform affirmative outreach to people eligible for certain vaccinations, such as the pneumovax and shingles vaccine, both of which are available to a subset of the population.

(Id.; Doc. 203 (Venters Decl.) ¶ 53.)

Given the primacy of vaccines in reducing risks from COVID-19 (see Doc. 201-7 at 16, CDC May 3, 2022 Guidance ("Vaccination remains the best tool to prevent severe illness and death from COVID-19")), there is a genuine issue of material fact that "a reasonable official in the circumstances [at CAFCC] would have appreciated the high degree of risk involved" to USMS detainees from the facility's low vaccination rates, including low booster rates. Roman, 977 F.3d at 943. Showing a due process violation therefore depends on whether Defendants have failed to take "reasonable available measures to abate that risk." Id.

Plaintiffs' criticisms that CAFCC's educational materials, including its "Here's the Scoop" poster, do not specifically encourage detainees to get the vaccine and, unlike the AMEND project materials, are not tailored to an incarcerated audience, are insufficient to make this showing. In addition to the official vaccination information sheets and the "Here's the Scoop" poster—which also appears on the sign-in page of detainee tablets—Plaintiffs do not dispute that, prior to holding vaccination events, CAFCC officials held town hall meetings in the housing units to answer questions about the vaccine and provided multiple opportunities for detainees to obtain the vaccine or discuss their medical concerns and questions about the vaccine with a medical professional in a confidential setting.

As to ongoing education, it is not disputed that new detainees are offered vaccinations on intake and instructed how to request a vaccine. Taking as true that using the AMEND project, rather than CAFCC's educational materials would better inform and encourage detainees to get the vaccine, Plaintiffs have not produced any evidence that these or similar materials were reasonably available to Defendants and Defendants made a conscious decision to reject them. Moreover, merely pointing out new or novel approaches to promote vaccinations within incarcerated populations does not create a genuine issue of material fact that Defendants' approaches are objectively unreasonable. Where it is undisputed that CAFCC makes vaccinations available to all detainees and provides information in the housing units and on detainee tablets about how to request vaccinations, CAFCC's failure to use more robust or better targeted materials does not show a reckless disregard for the risks of detainees not being fully vaccinated. "[T]he Supreme Court has instructed that 'mere lack of due care by a [government] official' does not 'deprive' an individual of life, liberty, or property under the Fourteenth Amendment." Castro, 833 F.3d at 1071 (quoting Daniels v. Williams, 474 U.S. 327, 330-31, 106 S.Ct. 662, 88 L.Ed.2d 662 (1986)) (internal quotation marks and citation omitted).

Plaintiffs' arguments about boosters and targeting immunocompromised individuals for vaccines present a closer question. Plaintiffs have raised a genuine issue of material fact that CAFCC does not offer COVID-19 boosters to detainees on intake, even when it is clear from the intake responses that they are eligible for a booster. (PSOF ¶ 249.) It is also undisputed that CAFCC staff do not enter

or reminders in their electronic medical system to track a detainees' eligibility for boosters and/or schedule them for boosters and instead only provide boosters when detainees specifically request them. Expert testimony from Dr. Murray and Dr. Venters also shows that correctional healthcare systems generally make affirmative efforts to track and schedule medically recommended tests and vaccinations in other contexts and do not rely on individual detainees to do so on their own.

Defendants argue that it is reasonable to expect detainees to know when they are eligible for a booster in the COVID-19 context because detainees who receive vaccinations at CAFCC are given a vaccination card stating the type of vaccine they received and when they received it. (Doc. 221 at 19.) But this only accounts for the subset of detainees who become fully vaccinated at CAFCC and does not address the unknown number of CAFCC detainees who received their vaccinations elsewhere and who are not eligible for boosters. So, a reasonable fact finder could conclude that relying on detainees to know and track their booster eligibility based on their vaccination cards, even if in their possession, instead of taking measures to track and offer boosters to detainees like correctional institutions routinely use for other recommended tests and vaccinations, is objectively unreasonable. Therefore, a question of fact remains about whether these deficiencies amount to a due process violation.

Similarly, there is a question of fact whether Defendants fail to effectively track and target high risk or immunocompromised detainees for vaccinations. And there is a question of fact whether failure to do so constitutes reckless disregard to the heightened risk of harm to these detainees of contracting COVID-19, of which a reasonable official would know. Defendants point out that Clinical Director Rose only stated that, due to high detainee turnover, maintaining a current "list" of detainees with COVID-19 risk factors became impractical; she did not state that high-risk detainees would not otherwise be flagged for boosters. (Doc. 221 at 17.) Rose clarified that, even though CAFCC no longer attempts to keep a running list of all high-risk detainees, "individual medical files still contain information about each detainee's medical conditions such that providers are aware of the detainee's risk factors while they are treating them" and medical staff can produce reports of detainees by risk factor when there is a need to do so. (Id.; Doc. 192-2, Ex. 3 (Rose Decl.) ¶¶ 46-47.) But this evidence falls short of showing that Defendants have developed any strategies to affirmatively identify high risk or immunocompromised detainees. It suggests that such individuals are not specifically targeted for vaccines, boosters, or any other protective measures unless they seek out a medical appointment or otherwise come across the "radar" of the Medical Director or another provider, even though CAFCC clearly has an ability to track and target such individuals. Given the well-established heightened health risks to such individuals who contract COVID-19, coupled with the low rate of vaccinations and boosters at CAFCC overall, a reasonable fact finder could determine that failing to use reasonable available measures to track and reach out to immunocompromised individuals is reckless disregard to a serious risk of harm that any reasonable correctional official would appreciate. Therefore, a question of fact remains about whether CAFCC's failure to take reasonable available measures to track and target high risk individuals for vaccines and other COVID-19 protections amounts to a due process violation.

ii. Intake Cohorts

Plaintiffs argue that CAFCC's discontinuation of intake cohorts as of

June 1, 2022 was objectively unreasonable because the CDC continues to recommend routine observation periods under its Enhanced COVID-19 Prevention Strategies, and a number of factors at CAFCC call for enhanced prevention. (Doc. 200 at 21-25.)

In addition to whether Community levels are medium or high, the CDC's May 3, 2022 Guidance sets forth four facility-level factors staff should consider when deciding whether to add or remove enhanced protective strategies. First, "[f]acilities that do not have high up to date vaccination coverage should consider applying enhanced prevention strategies even when the COVID-19 Community Level is low." (Doc. 201-7 at 5.) Second, staff should consider shifting to enhanced protection strategies when any staff or resident in the facility tests positive for COVID-19 and follow-up testing of close contacts identifies "one or more additional cases," indicating transmission is occurring within the facility. (Id.) Third, staff should consider "risk of severe health outcomes," by first determining whether staff or residents are "likely to get very sick from COVID-19," and, if so, consider switching to enhanced protective measures if staff are "unable to do one of the following: (a) assess and administer COVID-19 therapeutics on site to prevent severe health outcomes among residents more likely to get very sick from COVID-19, OR (b) assess residents' risk for severe outcomes and ensure timely access to care outside the facility." (Id.) Fourth, staff are to consider whether facility and structural characteristics, such as dense housing arrangements or frequent turnover may require some enhanced prevention strategies, even when the COVID-19 community level is low. (Id.)

Plaintiffs argue that each of these factors support enacting enhanced prevention strategies at CAFCC, including the resumption of intake cohorts. (Doc. 200 at 23-25.) As to vaccination rates, Plaintiffs' expert Dr. Venters states that "CAFCC has not sufficiently tracked its vaccination rates, and the available data suggest that CAFCC lacks high vaccination rates and the willingness to track them," which Dr. Venters opines triggers the need for enhanced protection measures. (Doc. 200 at 23; Doc. 203, Venters Decl. ¶ 30.) In addition to its low vaccination rates, Plaintiffs argue that the transmission rate at CAFCC also calls for enhanced protection measures. (Doc. 200 at 24.) Based on the 1,782 COVID-19 positive cases Defendants have identified over the more than two years of this litigation, Plaintiffs calculate that CAFCC averages more than 2 new cases each day, with a higher amount occurring in the past year, which they argue represents a high degree of internal spread. Dr. Venters also cites to charts showing multiple units at CAFCC on quarantine at any given time as indicative that, at any given time, there has been recent transmission in the facility, from which he opines that "it is highly likely" that the transmission rate inside CAFCC calls for enhanced protections. (Venters Decl. ¶ 31.) As to the risk of severe health outcomes, Plaintiffs argue that CAFCC's failures to

Plaintiffs claim, based on a mortality rate calculation in Dr. Murray's April 29, 2022 report of "0.15 % (2/1332)," that CAFCC had 1,322 positive cases as of the date of that report, compared to 1,782 in Defendants' Statement of Facts, and therefore added 450 positive cases between April 29, 2022 and July 2022, or a rate of over 4 new cases per day in a two-month period. Absent any discussion of when Dr. Murray made the mortality rate calculation in his report and what data he relied on at the time, the claim that CAFCC added 450 positive cases between April 29, 2022 and July 2022 is too speculative to credit. Nonetheless, it is undisputed that CAFCC had a higher number of identified COVID-19 infections in 2022, overall, than in the two previous years (560 in 2020, 516 in 2021, and 706 in 2022). (DKSOF ¶ 310.)

identify and track who is high risk and the unavailability of therapeutic medications on site also call for enhanced prevention strategies. (Doc. 200 at 24.) Finally, as to operational characteristics, Plaintiffs argue that high turnover at CAFCC also calls for applying some enhanced protective measures. (Id. at 24-25.)

Plaintiffs also claim that Defendants' decision to return to mandatory masking on June 30, 2022 based on increases in community and facility transmission (see DKSOF ¶ 99) shows that "Defendants admit they are currently required to put another enhanced protection, universal masking, in place," and they argue that, by "fail[ing] to implement the other enhanced protections, including intake quarantining, [Defendants] recklessly declined to make use of this important, available protective measure." (Doc. 200 at 25.)

Defendants argue that Plaintiffs misconstrue the CDC Guidance as "requir[ing]" intake cohorting whenever any of the identified community and facility factors point to increased risk, and they point out that "nothing in the guidelines is mandatory." (Doc. 221 at 19.) The Guidance itself states that it is "intended to provide guiding principles" and that "facilities and agencies might adapt CDC guidance for correctional and detention facilities based on their specific populations and operational needs." (Id.; Doc. 201-7 at 3.) As to facility-level factors, the Guidance also makes clear that "guidance is not available to set specific thresholds for these factors, or to specify how many factors to consider before shifting to enhanced prevention measures." (Id. at 4.) So, Defendants argue that "a 10% vaccination rate does not automatically require enhanced prevention measures ... nor does the fact that CAFCC experiences frequent detainee turnover." (Doc. 20 at 20-21.) Defendants also argue that Plaintiffs overemphasize the rise in transmissions in 2022. (Doc. 20 at 25.) They argue that the number of COVID-19 cases at CAFCC in 2022 was not significantly higher than in 2020 and 2021 (560 in 2020, 516 in 2021, and 706 in 2022), and even with the increase in 2022, only 3.9% of the 44,703 USMS detainees who have cycled through CAFCC since the start of the pandemic (and since testing became available) have tested positive for COVID-19, with mortality rates at a low 0.15%. (Doc. 221 at 20-21.)

There are, at a minimum, genuine issues of material fact that at least some or all of the CDC's enumerated facility factors calling for consideration of enhanced prevention strategies are met at CAFCC. Moreover, Defendants do not dispute that the vaccination rates at CAFCC are low, detainee turnover is high, and that other factors—such as the rates of community and facility transmission—prompted CAFCC to return to mandatory masking on June 30, 2022. (Doc. 221 at 20, n.14.)

Nonetheless, Plaintiffs have not created a triable issue of fact that Defendants' decision not to re-institute mandatory intake cohorting, in particular, is objectively unreasonable now that COVID-19 testing is widely available. It is undisputed that, as of July 2022, CAFCC tests all incoming detainees at intake, and it offers tests to all existing detainees if they develop symptoms. (DKSOF ¶¶ 155, 207.) CAFCC also quarantines or medically isolates all detainees who test positive or display COVID-19 symptoms, and it conducts

The cases Plaintiffs discuss as emphasizing the importance of quarantining new arrivals to correctional facilities (see Doc. 200 at 22-23) are inapplicable here because they are all from 2020 and predate the widespread availability of COVID-19 rapid tests, which the evidence shows CAFCC staff began using to screen all new arrivals in July 19, 2022. (DKSOF ¶¶ 148-149, 155.)

daily symptom screenings of detainees on the same pod as those quarantined. (Id. ¶¶ 179.) Intake observation periods are included among the enhanced protection strategies the CDC currently recommends facilities "consider" in response to heightened community and facility risk factors. But, the Guidance, itself, is discretionary and expressly calls for individualized assessments. Moreover, it is undisputed that CAFCC continues to implement all standard prevention strategies—including intake testing—and has adopted other enhanced prevention strategies, such as universal masking, based on its monitoring and assessment of community and facility transmissions. Plaintiffs have not put forth any evidence from which a reasonable fact finder could conclude that opting for only some, not all, of the CDC-recommended advanced strategies is objectively unreasonable or that the failure to specifically re-institute intake cohorts where CAFCC already requires testing at intake for the same purpose recklessly disregards a serious risk of harm to Plaintiffs.

iii. Antiviral Medications

Plaintiffs argue that Defendants' choice not to stock and administer Paxlovid and other antiviral medications and its failure to prescribe even a single dose of these therapies despite hundreds of positive COVID-19 tests since these medications became available is objectively unreasonable. (Doc. 200 at 25-27.) The CDC May 3, 2022 Guidance states that "antiviral medications are available that are effective in preventing severe health outcomes in persons with COVID-19" and explains that "[t]hese medications can be ordered at no cost through the [] Department of Health Services, from the manufacturer, or in some cases through the facilities' usual medication procurement mechanisms." (Doc. 201-7 at 16.) The Guidance refers to the National Institute of Health (NIH) COVID-19 Treatment Guidelines for information about these medications, and the NIH Treatment Guidelines, in turn, recommend Paxlovid or Remdesivere as the top two preferred medications for all unhospitalized COVID-19 patients who are at high risk of progressing to severe COVID-19. (Doc. 200 at 25; Doc. 201-10 at 3.)

According to Defendants' expert, Dr. Murray, the NIH Treatment Guidelines set out a standard of practice that correctional healthcare providers should consider when determining when to prescribe antiviral treatment. (Doc. 200 at 25; Doc. 201-1 at 36 (Murray Dep. at 165:11-24).) Dr. Murray also agreed that a detainee who tests positive for COVID-19 and has at least one CDC identified risk factor should be evaluated for Paxlovid within five days of symptom onset. (Doc. 201-1 at 39 (Murray Dep. at 172:12-18).) CDC-identified risk factors include age, being unvaccinated, and having underlying conditions, such as asthma, cancer, diabetes, and obesity.

"Underlying Medical Conditions Associated with Higher Risk for Severe COVID-19: Information for Healthcare Professionals," available at https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/underlyingconditions.html (last visited March 10, 2023.)

Defendants argue that Plaintiffs do not provide legal authority requiring CAFCC to stock Paxlovid or other antiviral medications or to prescribe them to detainees, and that it is sufficient for Fifth Amendment purposes that CAFCC can obtain these medications from local pharmacies when needed. They also argue that Plaintiffs have not produced evidence showing that the amount of time it would take for CAFCC staff to obtain such medications from a local pharmacy as opposed to having them stocked in the facility's internal pharmacy would put detainees at risk of serious harm. (Doc. 221 at 21-22.) Plaintiffs need not show that Defendants failed to comply with a specific legal requirement to demonstrate a due process violation; they need only show that Defendants "did not take reasonable available measures to abate th[e] risk" of harm to detainees under their care, "even though a reasonable official in the circumstances would have appreciated the high degree of risk involved." Roman, 977 F.3d at 943. As already discussed, there is a question of fact that a reasonable official would have appreciated the high degree of risk involved in not providing COVID-19 positive detainees with antiviral treatments, particularly to those with identified risk factors making them more vulnerable to severe illness and death.

A fact finder could also conclude that not having antiviral medications readily available to treat CAFCC COVID-19 positive detainees is not objectively reasonable. Guidance from the CDC and NIH make clear that such medications are available to detention facilities, potentially at no cost, and are recommended and effective for treating COVID-19 positive individuals and preventing severe health outcomes. Dr. Murray's opinion that COVID-19 positive detainees with at least one risk factor should be assessed for antivirals within five days of symptoms onset further suggests that it is not objectively reasonable for a correctional facility not to acquire and stock these treatments for those who need them.

Even though Defendants argue CAFCC medical staff can obtain these medications when prescribed, and Plaintiffs have not shown that the added time it would take to do so puts detainees at serious risk of harm, a reasonable fact finder could still infer that requiring this extra step where such medications are reasonably available is not objectively reasonable. Dr. Murray acknowledged that anyone with at least one risk factor should be evaluated for such treatment within five days of symptoms. Yet it is undisputed that CAFCC medical providers have never prescribed Paxlovid or any other antivirals to any of the hundreds of patients who have tested positive for COVID-19 at CAFCC since these medications became available. So there is at least a question of fact that CAFCC providers either fail to make this evaluation or simply choose not to prescribe these treatments, even when the standard of care may call for them, creating a question of fact that CAFCC's COVID-19 treatment practices are also objectively unreasonable.

To conclude, there are questions of fact whether Plaintiffs suffered a constitutional violation based on Defendants' failures to (1) offer boosters to detainees at intake and use detainees' electronic health records to track and recommend/schedule booster-eligible detainees for boosters, (2) utilize detainees' electronic health records to identify and target at risk/immunocompromised detainees for vaccinations and other COVID-19 protections, and (3) stock and prescribe CDC- and NIH-recommended antiviral treatments for COVID-19 positive patients with at least one CDC-identified risk factor. There are questions of fact on whether these failures constitute reckless disregard to risks of serious harm to Plaintiffs' health from COVID-19 of which a reasonable official would know, and these alleged failures are directly tied to Defendants' COVID-19 policies. There are also questions of fact that the related policies amount to reckless disregard for Plaintiffs' constitutional rights and present an "imminent" danger to Plaintiffs' health and safety. See Roman, 977 F.3d at 943. All the requirements of a Monell claim are therefore met, and the Court will deny summary judgment to Defendants, in part, based on these alleged violations. Because Plaintiffs have not raised genuine issues of material fact that any other aspects of Defendants' COVID-19 protections are objectively unreasonable, the Court will grant Defendants' Motion in part as to any remaining bases for their Fifth Amendment claims.

IT IS ORDERED:

(1) The reference to the Magistrate Judge is withdrawn as to Defendants' Motions for Summary Judgment (Doc. 187; Doc. 194), Plaintiffs' Motion to Exclude the Findings and Opinions of Defendants' Expert Dr. Owen J. Murray (Doc. 185) and Defendant Kline's Daubert Motion to Exclude the Testimony of Homer Venters (Doc. 189).

(2) Plaintiffs' Motion to Exclude the Findings and Opinions of Defendants' Expert Dr. Owen J. Murray (Doc. 185) and Defendant Kline's Daubert Motion to Exclude the Testimony of Homer Venters (Doc. 189) are denied.

(3) Defendants' Motions for Summary Judgment (Doc. 187; Doc. 194) are granted in part and denied in part as follows:

(a) The Motions are denied in part as to Defendants' alleged failures to
(i) offer boosters to CAFCC detainees at intake and use available electronic health records to recommend/schedule boosters for booster-eligible detainees,
(ii) utilize available electronic health records to identify and target at risk/immunocompromised detainees for vaccinations and other COVID-19 protections, and
(iii) stock and prescribe CDC- and NIH-recommended antiviral treatments for COVID-19 positive patients with at least one CDC-identified risk factor.
(b) The Motions are granted in part as to any remaining bases for Plaintiffs' Fifth Amendment claims.

(4) This action is referred by random lot to Magistrate Judge for the purpose of conducting a settlement conference.

(5) The parties must jointly contact the chambers of Magistrate Judge Michael T. Morrissey at 602 322-7680 within 14 days of the date of this Order to schedule a settlement conference.

AMENDED ORDER ON RECONSIDERATION

This Order amends the Court's Order at Doc. 240 only insofar as it corrects the date set for the scheduled Settlement Conference from July 26, 2023, to July 17, 2023, per Doc. 235.

Defendant Kline filed a "Motion for Reconsideration of the Order Denying in Part His Motion for Summary Judgment (Doc. 231)," which Federal Defendants join. (Docs. 232, 233). The Court permitted Plaintiffs to respond, and Plaintiffs filed a Response (Doc. 237). No reply briefs were permitted.

The Court will deny Defendants' Motion/Joinder.

I. Background

Plaintiffs, former pretrial detainees in CoreCivic's Central Arizona Florence Correctional Complex (CAFCC), initiated this class action in May 2020, early in the COVID-19 pandemic, seeking declaratory and injunctive relief on behalf of themselves and all similarly situated individuals confined at CAFCC. (Doc. 1.) Plaintiffs sued Defendant CAFCC Warden Kline and Federal Defendants Van Bayless, Acting United States Marshall for the District of Arizona, Donald Washington, Director of the U.S. Marshall's Service, and Michael Carvajal, Director of the Federal Bureau of Prisons, in their official capacities, alleging that CAFCC failed to take reasonable available measures to protect Plaintiffs

from exposure to COVID-19 in violation of their Fifth Amendment due process rights. (Id.)1

On March 30, 2023, the Court granted Defendants' Motion for Summary Judgment on most issues alleged in the Complaint but found genuine issues of material fact whether CAFCC failed to take reasonable available measures to (1) offer COVID-19 boosters to detainees at intake and use electronic health records to recommend/schedule boosters, (2) use electronic health records to identify and target at-risk/immunocompromised detainees for COVID-19 vaccinations and other protections, and (3) stock and prescribe CDC- and NIH-recommended antiviral treatments for COVID-19 positive patients. (Doc. 231.) The Court ordered the parties to engage in a settlement conference. (Id. at 46-47.) Defendants now move for reconsideration, arguing that new evidence, including updated guidance from the Centers for Disease Control and Prevention (CDC), calls for dismissal of this action in its entirety.

II. Legal Standards

A. Reconsideration

The Court has discretion to reconsider and vacate a prior order. Barber v. Hawaii, 42 F.3d 1185, 1198 (9th Cir. 1994); United States v. Nutri-cology, Inc., 982 F.2d 394, 396 (9th Cir. 1992). "The Court will ordinarily deny a motion for reconsideration of an Order absent a showing of manifest error or a showing of new facts or legal authority that could not have been brought to its attention earlier with reasonable diligence." LRCiv 7.2(g)(1). Any motion for reconsideration must specifically identify the matters that were overlooked or misapprehended by the Court. Id. If any new matters are being brought to the Court's attention for the first time, the movant must identify the reasons they were not presented earlier, and any specific modifications being sought in the Court's Order. Id. No motion for reconsideration of an Order may repeat any oral or written argument made in support of, or in opposition, to the motion that resulted in the Order. Id.

B. Fifth Amendment

The government or private entity responsible for the government function of incarcerating pre-trial detainees is found to have violated its constitutional duty under the Due Process Clause to provide a detainee "conditions of reasonable health and safety" when:

(i) [It] made an intentional decision with respect to the conditions under which the plaintiff was confined;
(ii) those conditions put the plaintiff at substantial risk of suffering serious harm;
(iii) the [government or private entity] did not take reasonable available measures to abate that risk, even though a reasonable official in the circumstances would have appreciated the high degree of risk involved ...; and
(iv) by not taking such measures, the [government or private entity] caused the plaintiff's injuries.

Roman v. Wolf, 977 F.3d 935, 943 (9th Cir. 2020) (alternations in original) (quoting Gordon v. Cnty. of Orange, 888 F.3d 1118, 1125 (9th Cir. 2018) (discussing the "objective deliberate indifference standard")). III. Analysis

Defendants argue that the CDC updated its COVID-19 Guidance for detention facilities on November 29, 2022, while Defendants' Motion for Summary Judgment was still pending, leading to more relaxed standards for COVID-19 protections. (Doc. 232 at 2-4.) They also note that, on April 10, 2023, President Biden signed a congressional resolution ending the COVID-19 national emergency, and on or about March 2, 2023, the United States Department of Health and Human Services (HHS) announced it was planning for the public health emergency to expire on May 11, 2023. (Id. at 4-5.) Defendants argue that these developments and low community levels of COVID-19 nationwide, and in Arizona and Pinal County specifically, constitute new evidence that could not have been brought to the Court's attention during summary judgment briefing and call for reconsideration of the Court's partial denial of their Motion for Summary Judgment. (Id. at 5-6.) Throughout their Motion for Reconsideration, Defendants incorporate information from official government websites, including the CDC website, to show that current COVID-19 conditions do not support Plaintiffs' claims for relief.2

A. COVID-19 Boosters

On summary judgment, the Court found that

Plaintiffs have raised a genuine issue of material fact that CAFCC does not offer COVID-19 boosters to detainees on intake, even when it is clear from the intake responses that they are eligible for a booster. (PSOF ¶ 249.) It is also undisputed that CAFCC staff do not enter notes or reminders in their electronic medical system to track detainees' eligibility for boosters and/or schedule them for boosters and instead only provide boosters when detainees specifically request them. Expert testimony from Dr. Murray and Dr. Venters also shows that correctional healthcare systems generally make affirmative efforts to track and schedule medically recommended tests and vaccinations in other contexts and do not rely on individual detainees to do so on their own.

(Doc. 231 at 38.) The Court determined that "a reasonable fact finder could conclude that" failing to implement measures "to track and offer boosters to detainees like correctional institutions routinely use for other recommended tests and vaccinations[] is objectively unreasonable." (Id.)

The CDC's November 29, 2022 "Guidance on Management of COVID-19 in ... Detention Facilities" now recommends for vaccines: "Encourage and enable staff, volunteers, and residents to stay up to date on COVID-19 vaccination. Where possible, offer the vaccine onsite and support peer outreach to promote vaccination." (Doc. 238 at 6.) Defendants reiterate that, at summary judgment, it was undisputed CAFCC began offering vaccines and boosters to all CAFCC detainees over age 18 in March 2021 and has never run out of doses; information about how to obtain a booster is posted and is available in a handbook; and detainees may request boosters via medical request forms. (Doc. 232 at 6-7 (citing Doc. 231 at 13-14).) Based on these facts, they argue, "Plaintiffs

cannot seriously contend that CoreCivic's efforts to make vaccines and boosters available at CAFCC fail to 'encourage and enable' Plaintiffs to get vaccines and boosters, or that the COVID-19 vaccine and boosters are not available onsite." (Doc. 232 at 7.) Defendants also argue that, even if Plaintiffs can show CAFCC does not offer boosters at intake, this would not show its policies on boosters are objectively unreasonable or in "reckless disregard" to detainee health. (Id.)

Plaintiffs argue that Defendants have failed to produce new evidence in support of their Motion because the CDC's November 2022 Guidance does not materially differ from the May 2022 Guidance the Court relied on at summary judgment. (Doc. 237 at 6.) The earlier Guidance similarly recommended that facilities "[c]ontinue to provide and encourage up to date COVID-19 vaccination for staff members and residents (including boosters, as well as additional doses for people with weakened immune systems and for others who are eligible for additional doses)," and did not enumerate specific steps facilities should follow to carry out these recommendations. (Doc. 192-2 at 90.) Plaintiffs argue that there are therefore no substantive changes from the CDC that call for reconsideration of the Court's denial of summary judgment on CAFCC's booster policies.

Plaintiffs also note that the Court did not rely on the CDC Guidance to find a question of fact whether CoreCivic's booster policies were objectively reasonable. (Doc. 237 at 6.) Instead, the Court cited the expert opinions of Dr. Murray and Dr. Venters that correctional institutions generally perform affirmative outreach to detainees who become eligible for recommended medical tests and vaccinations in other contexts. From this, the Court found a question of fact whether CAFCC's failure to do so for COVID-19 boosters was objectively unreasonable. (Id. at 7.)

Defendants previously emphasized in their summary judgment briefing that the CDC Guidance is not intended to enumerate the precise prevention measures each institution must follow to reduce the risk of COVID-19 but is "intended to provide guiding principles" that facility administrators must adapt "based on their specific populations and operational needs." (Id.; Doc. 201-7 at 3.) The lack of specificity in the CDC Guidance for how to encourage and increase COVID-19 vaccination/booster uptake is therefore not dispositive of whether a reasonable jury could find CAFCC's failures to offer COVID-19 boosters at intake or to use its available electronic health records to track and recommend/schedule detainees for boosters is objectively unreasonable.

As noted, the Court previously relied primarily on Dr. Murray's and Dr. Venters' expert opinions about the reasonable measures correctional facilities generally take to prevent other serious risks to detainee health, such as annual tuberculosis testing and scheduling inmates for shingles and other recommended vaccines. Dr. Venter opined that

[s]ome of the most basic functions of correctional health departments involve scheduling healthcare measures after particular time intervals, even when this healthcare might not be scheduled in this way in the community. For example, in carceral settings, tuberculosis tests are recommended on an annual interval. Correctional healthcare systems generally take affirmative efforts to schedule these tests after a year has passed, rather than waiting for individual detained people to request them. Correctional healthcare systems also generally perform affirmative outreach to people

eligible for certain vaccinations, such as the pneumovax and shingles vaccine, both of which are available to a subset of the population.

(Doc. 231 at 236 (quoting Doc. 203 (Venters Decl.) ¶ 53).)

The Court also relied on facts specific to CAFCC, such as its low vaccination and booster rates, to find a question of fact whether a reasonable official under like circumstances would have appreciated the high degree of risk of not adopting such "reasonable available measures" to abate the spread of COVID-19. (Doc. 231 at 36-37.)

Defendants do not point to any new evidence that vaccination and booster rates at CAFCC have significantly increased since their summary judgment briefing or that the risks to detainees of contracting COVID-19 in the incarceration setting is any less than the risk of contracting other communicable diseases for which correctional facilities routinely track and schedule inmates for recommended tests and vaccines. The new evidence Defendants produce from the CDC also does not call for reconsideration of the Court's previous findings on this issue, and the Court will deny Defendants' Motion for Reconsideration regarding their booster policies.

B. Tracking Immunocompromised Detainees

On summary judgment, the Court found questions of fact "whether Defendants fail to effectively track and target high risk or immunocompromised detainees for vaccinations" and "whether failure to do so constitutes reckless disregard to the heightened risk of harm to these detainees of contracting COVID-19, of which a reasonable official would know." (Doc. 231 at 39.) As above, this finding was based, in part, on the uncontroverted evidence of low vaccination/booster rates at CAFCC. It was undisputed CAFCC has available electronic health records to track and target immunocompromised individuals for vaccines but had not developed any strategies to do so. Thus, the Court concluded that "a reasonable fact finder could determine that failing to use reasonable available measures to track and reach out to immunocompromised individuals is [in] reckless disregard to a serious risk of harm that any reasonable correctional official would appreciate." (Id.)

Defendants acknowledge that the CDC's updated November 2022 Guidance "recommends that CoreCivic '[a]ssess what portion of people in the facility are more likely to get very sick from COVID-19, for example, due to underlying health conditions, older age, pregnancy, or poor access to medical care,'" but they argue that they are nonetheless entitled to reconsideration because the Guidance "does not specify any particular format for doing so." (Doc. 232 at 7; see Doc. 238 at 6.) Defendants contend it is sufficient that detainees' individual medical files contain this information, and they argue, "Plaintiffs cannot seriously contend that CoreCivic is unaware of those detainees at CAFCC who are 'more likely to get very sick from COVID-19.'" (Id. at 8.)

The Court already rejected these arguments at summary judgment, finding that the testimonial evidence Defendants produced about how at-risk detainees were tracked at CAFCC was vague, and it

[s]uggest[ed] that [at-risk] individuals are not specifically targeted for vaccines, boosters, or any other protective measures unless they seek out a medical appointment or otherwise come across the "radar" of the Medical Director or another provider, even though CAFCC clearly has an ability to track and target such individuals.

(Doc. 231 at 39.) The Court also concluded that "a question of fact remains about

whether CAFCC's failure to take reasonable available measures to track and target high risk individuals for vaccines and other COVID-19 protections amounts to a due process violation." (Id.)

The CDC's lack of specificity in both its May and November 2022 Guidance for how correctional facilities should track high risk detainees for COVID-19 protections does not call for reconsideration of the Court's conclusion that there is a triable issue of fact whether CAFCC's failure to adopt reasonable available measures to do so is objectively unreasonable. Defendants offer no new evidence about how CAFCC tracks and targets high risk detainees that would call for reconsideration of this conclusion. Instead, Defendants merely ask the Court to "rethink what it already thought" regarding its tracking efforts, which is not grounds for reconsideration. "A motion for reconsideration should not be used to ask the court 'to rethink what the court had already thought through—rightly or wrongly.'" West Thomas Bldg. Enterprises v. Soetantyo, 976 F. Supp. 1298, 1302 (D. Ariz.), affirmed, 111 F.3d 138 (9th Cir. 1997). (internal quotation marks and citation omitted). Defendants' Motion for Reconsideration is denied concerning CAFCC's tracking of immunocompromised detainees.

C. Antiviral Medications

On summary judgment, it was undisputed that the CDC recommended treating COVID-19 positive patients with antiviral medications, such as Paxlovid and Remdesivir, which were readily available to CAFCC. Yet, CAFCC did not stock these medications and "had never prescribed Paxlovid or any other antivirals to any of the hundreds of patients who ha[d] tested positive for COVID-19 at CAFCC since these medications became available." (Doc. 200 at 5-7.) The Court found there is a question of fact that CAFCC providers either fail to evaluate patients' eligibility for such treatments "or simply choose not to prescribe these treatments, even when the standard of care may call for them," which, in turn, created a question of fact "that CAFCC's COVID-19 treatment practices are ... objectively unreasonable." (Doc. 231 at 45.)

The November 2022 CDC Guidance continues to promote the use of antivirals in the incarceration context, stating that "[e]ffective treatments are now widely available and must be started within a few days after symptoms develop to be effective. [Facilities should] support timely treatment for those eligible; facilities without onsite healthcare capacity should plan to ensure timely access to offsite care." (Doc. 238 at 7.) CAFCC has onsite health clinics capable of administering medications, yet Defendants argue as they did previously that CAFCC's failure to stock these medications is immaterial because "[n]othing in the guidance requires a facility to keep a stock of such treatments onsite or requires that a facility provide them to a certain percentage of the population." (Doc. 232 at 8.) The Court previously rejected similar arguments, stating,

Plaintiffs need not show that Defendants failed to comply with a specific legal requirement to demonstrate a due process violation; they need only show that Defendants "did not take reasonable available measures to abate th[e] risk" of harm to detainees under their care, "even though a reasonable official in the circumstances would have appreciated the high degree of risk involved"....
[a] fact finder could ... conclude that not having antiviral medications readily available to treat CAFCC COVID-19 positive detainees is not objectively reasonable.

(Doc. 231 at 44 (quoting Roman, 977 F.3d at 943.) In moving for reconsideration, Defendants

overlook that the Court found both that "[a] fact finder could ... conclude that not having antiviral medications readily available to treat CAFCC COVID-19 positive detainees is not objectively reasonable" and that the record showing CAFCC had never prescribed antivirals since the CDC began recommending them, even though they were readily available, created at least a question of fact that CAFCC's COVID-19 treatment practices were not objectively reasonable. (Id. at 44-45.)

Defendants have not presented any new evidence showing that antiviral treatments are no longer medically recommended for COVID-19 positive patients, particularly those with at least one CDC-recognized risk factor, and a reasonable fact finder could conclude that this applies to at least some affected CAFCC detainees. Defendants also have not shown that CAFCC has ever prescribed any antiviral treatments since these treatments became available, and they have not shown that the number and severity of COVID-19 cases in CAFCC has decreased making antiviral treatments no longer medically indicated for any CAFCC COVID-19 patients. Accepting that CAFCC can readily obtain antiviral medications from local pharmacies when its medical staff find such treatments appropriate, questions of fact remain about why CAFCC has not done so even though the CDC and NIH have promoted them as being readily available and highly effective for treating some COVID-19 positive individuals and preventing severe health outcomes. (See Doc. 231 at 44-45.)

In summary, Defendants have not presented any newly discovered evidence or material changes in circumstances within CAFCC that would call for the Court to reconsider its prior findings. In his Motion for Reconsideration, Defendant Kline refers generally to presidential and HHS pronouncements that COVID-19 is no longer a national emergency/public health crisis, and in their Joinder, Federal Defendants cite to the World Health Organization's announcement that COVID-19 no longer constitutes an international public health emergency due to "the decreasing trend in COVID-19 deaths, the decline in COVID-19 related hospitalizations and intensive care unit admissions, and the high levels of population immunity." (Doc. 232 at 1-2, 9; Doc. 233 at 1.) Apart from showing that the risk of COVID-19 has decreased significantly in the general population, Defendants fail to link these changes to the specific CAFCC prevention measures the Court determined a reasonable fact finder could find objectively unreasonable within the detention setting. Nor do they show that the small subset of measures discussed herein no longer apply. Essentially, Defendants rehash the same arguments they made on summary judgment which is improper grounds for reconsideration. See LRCiv 7.2(g)(1) ("No motion for reconsideration of an Order may repeat any oral or written argument made in support of ... the motion that resulted in the Order.") The Court will deny Defendant Kline's Motion for Reconsideration and Federal Defendants Joinder in that Motion.

IT IS ORDERED:

(1) The reference to the Magistrate Judge is withdrawn as to Defendant Kline's Motion for Reconsideration (Doc. 232) and Federal Defendants' Joinder (Doc. 233), and the Motion and Joinder are denied.

(2) The Settlement Conference currently set for July 17, 2023 will proceed as scheduled.

Dated this 12th day of May, 2023.


Summaries of

Romero-Lorenzo v. Koehn

United States District Court, D. Arizona
Mar 29, 2023
665 F. Supp. 3d 1056 (D. Ariz. 2023)
Case details for

Romero-Lorenzo v. Koehn

Case Details

Full title:Claudia ROMERO-LORENZO, et al., Plaintiffs, v. Brian KOEHN, et al.…

Court:United States District Court, D. Arizona

Date published: Mar 29, 2023

Citations

665 F. Supp. 3d 1056 (D. Ariz. 2023)